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Abstract 
 
The covalent attachment of lipoic acid to the lipoyl domains (LDs) of the central 
metabolism enzymes pyruvate dehydrogenase (PDH) and oxoglutarate 
dehydrogenase (OGDH) is essential for their activation and thus for respiratory 
growth in the bacterium Escherichia coli and the yeast Saccharomyces 
cerevisiae. A third lipoic acid-dependent enzyme system, the glycine cleavage 
system (GCV), is required for utilization of glycine as a nitrogen source.  
In E. coli, lipoic acid is assembled on the LDs from the eight-carbon fatty acid, 
octanoate, in two steps. First, an octanoyltransferase (LipB) transfers an octanoyl 
moiety from the acyl carrier protein (ACP) of fatty acid biosynthesis to the LDs. A 
thioester-bound acyl-enzyme intermediate is formed in the process. Then lipoyl 
synthase (LipA) catalyzes replacement of single hydrogen atoms at carbons 6 
and 8 with sulfur atoms using radical SAM chemistry. Alternatively, either 
exogenous lipoic acid or octanoate can be directly attached to the LDs by lipoate-
protein ligase (LplA) via an acyl–AMP intermediate. 
E. coli strains containing null mutations in lipB are auxotrophic for either lipoic 
acid (or octanoate), or acetate plus succinate which respectively bypass the 
PDH- and OGDH-catalyzed steps required for aerobic growth on glucose minimal 
media. Spontaneously-arising mutant strains that retained the lipB mutation, yet 
did not require supplementation for aerobic growth were isolated. Initial 
characterization distinguished two types of suppressor strains. In chapter 2 I 
describe one type in which suppression was caused by single missense 
mutations within the coding sequence of the lplA gene. The LplA proteins 
encoded by the mutant genes had reduced Km values for free octanoate, which 
was detected in the cytoplasm at a concentration of about 28.2 μM, well above 
the Km values for the mutant LplA proteins. Thus in these suppressor strains, the 
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mutant LplA proteins utilize the cytoplasmic octanoate pool to activate PDH and 
OGDH enabling growth. 
In the second type of lipB suppressor strains, the causative mutation was a stop 
codon in the sdhB gene, which encodes a subunit of succinate dehydrogenase 
(SDH). In chapter 3, these lipB sdhB strains are further characterized. I show that 
these strains contain active PDH and require a functional lplA gene. Succinate in 
this strain is produced by three enzymes, any one of which will suffice in the 
absence of SDH. These three enzymes are: trace levels of OGDH, the isocitrate 
lyase of the glyoxylate shunt, and aspartate oxidase, the enzyme catalyzing the 
first step of nicotinamide biosynthesis.  
In chapter 4, I characterize the lipoate-protein ligase of the yeast S. cerevisiae. 
The E. coli LplA was the first lipoate-protein ligase (Lpl) to be characterized. It 
catalyzes two partial reactions: activation of the acyl chain by formation of acyl-
AMP, followed by transfer of the acyl chain to the LDs. It turns out that there is a 
surprising diversity within the Lpl family of enzymes, several of which catalyze 
reactions other than ligation reactions. For example, the Bacillus subtilis Lpl 
homologue LipM is an octanoyltransferase that transfers the octanoyl moiety 
from octanoyl-ACP specifically to GCV. Another B. subtilis Lpl homologue, LipL, 
transfers octanoate from octanoyl-GCV to other LDs in an amido-transfer 
reaction. In chapter 4, I report that the Lip3 Lpl homologue of S. cerevisiae has 
octanoyl-CoA:protein transferase activity, and discuss implications of this activity 
on the physiological role of Lip3 in lipoic acid synthesis. 
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Chapter 1: Introduction 
 
Discovery and Structural Characterization of Lipoic Acid 
In the fourth and fifth decades of the 20th century, several publications appeared 
describing “factors” that stimulated microbial growth when added in small 
amounts to growth media. For example, Esmond Snell reported on a factor that 
replaced acetate in the growth medium of certain lactic acid bacteria presumably 
because it enabled the bacteria to produce their own acetate (Guirard et al., 
1946). O’Kane and Gunsalus characterized the “pyruvate oxidation factor” which 
was essential for the conversion of pyruvate to acetate and CO2 by Enterococcus 
faecalis (O'Kane D and Gunsalus, 1948). Finally the “B. R. factor” described by 
Kline and Barker was required by Butyribacterium rettgeri for growth on lactate 
(Kline and Barker, 1950)1. It became apparent later that all these investigators 
were studying the same enzyme cofactor, lipoic acid.  
Several years later in the fall of 1950, through a collaboration between Gunsalus, 
Reed and the Eli Lilly Research Laboratories, 30 mg of a yellow crystalline 
compound were extracted from approximately 10 tons of liver residue and named 
alpha lipoic acid (Reed, 2001).  At the time it had been observed that the lipoic 
acid-catalyzed pyruvate oxidation by pigeon brain tissue was inhibited by trivalent 
arsenicals (such as Lewisite), which are known to bind sulfhydryl groups. 
Inhibition was reversible by dithiols such as 2,3-dimercaptopropanol (British anti-
Lewisite or BAL) but not by monothiols (Peters and Wakelin, 1949). It was thus 
postulated that lipoic acid would contain a dithiol. This was confirmed when the 
correct structure of the molecule was established as 6,8-dithiooctanoic acid by 
chemical synthesis (Reed, 1998) (Fig. 1.1).  
                                            
1
 The exact role of lipoic acid in B. rettgeri metabolism remains elusive because lipoic acid 
supplementation is not required for growth on either glucose or pyruvate, but is required for 
(anaerobic) growth on lactate. KLINE, L., PINE, L. & BARKER, H. A. 1963. Metabolic Role of the 
BR Factor in Butyribacterium rettgeri. J Bacteriol, 85, 967-75, WITTENBERGER, C. & FLAVIN, 
M. 1963. Butyribacterium rettgeri: a Role of Lipoic Acid in Anaerobic Electron Transport. Journal 
of Biological Chemistry, 238, 2529-2535. 
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Physiological Role of Lipoic Acid-Dependent Enzyme Systems 
There are five enzyme systems known to require lipoic acid for function. These 
are pyruvate dehydrogenase (PDH), 2-oxoglutarate dehydrogenase (OGDH), 
glycine cleavage (GCV), branched-chain 2-oxoacid dehydrogenase (BCDH), and 
acetoin dehydrogenase (ADH). The overall reactions catalyzed by these enzyme 
systems take place in multiple steps each occurring at a different subunit. In each 
system lipoic acid functions to carry reaction intermediates between the various 
subunits (Perham, 2000). Reduced NADH, which can be used by the cell to fuel 
biosynthesis reactions, is produced in the final step.  
PDH plays a central role in aerobic metabolism. It catalyzes the oxidative 
decarboxylation of pyruvate, the end product of glycolysis, to acetyl-CoA. Energy 
is conserved in the final product in the form of a thioester bond between acetate 
and coenzyme A (CoA). The acetate moiety of acetyl-CoA can then be 
condensed with oxaloacetate to form the first intermediate of the tricarboxylic 
acid (TCA) cycle, namely citrate. Additionally, acetyl-CoA is the building block for 
fatty acid biosynthesis. PDH is important for aerobic growth of Escherichia coli 
because the other major pyruvate- disassimilating enzyme, pyruvate:formate 
lyase (Pfl), has an oxygen labile active site and is thus inactive in the presence of 
air (Böck, 1996). E. coli contains a third pyruvate-metabolizing enzyme, pyruvate 
oxidase (PoxB), however it is mainly expressed during early stationary phase 
(Abdel-Hamid et al., 2001). Additionally PoxB is less efficient at energy 
conservation because it produces free acetate, which must be activated to 
acetyl-CoA at the expense of an ATP.  
After a few reactions of the TCA cycle, citrate is broken down to 2-oxoglutarate, 
which undergoes oxidative decarboxylation to succinyl-CoA by OGDH, a second 
lipoic acid-dependent enzyme system. Succinyl-CoA is required for the synthesis 
of the amino acids lysine and methionine, and the peptidoglycan component 
diaminopimelic acid. Additionally succinly-CoA is the source of succinate, which 
is the entry point to respiration. Succinate is also a precursor for heme synthesis 
in some organisms, but not in E. coli (Beale, 1996). OGDH activity is dispensable 
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under conditions where the TCA cycle operates as a branch. In such instances, 
fumarate is the source of succinate and succinyl-CoA.   
The third lipoic acid-dependent enzyme system, GCV, catalyzes cleavage of 
glycine to ammonia, and C1 units which are carried on tetrahydrofolate (THF). 
GCV is essential for utilization of glycine as sole source of nitrogen. The C1 units 
are used in various cellular processes including purine biosynthesis, methionine 
biosynthesis, formylation of Met-tRNA (to be used in translation initiation), and 
methylation of DNA, RNA and protein. GCV is an important enzyme for C3 plants 
(Douce et al., 2001). In these plants, the fortuitous oxidation of ribulose 1,5-
bisphosphate (termed photorespiration) produces the byproduct 2-
phosphoglycolate (2PG) which cannot be further metabolized by the Calvin 
Cycle. 2PG is converted to glycine, broken down by GCV and used to make 
serine via serine hydroxymethyltransferase. Serine then feeds into central 
metabolism at pyruvate. 
The lipoic acid-dependent BCDH is involved in breakdown of the branched-chain 
amino acids, valine, leucine and isoleucine, to their respective branched-chain 
acyl-CoAs which are used to make branched-chain fatty acids. Initially the amino 
acids undergo transamination of their amino groups, giving rise to 2-oxoacids 
which are decarboxylated by BCDH. Branched-chain fatty acids are produced by 
a number of bacteria in order to regulate membrane fluidity.(Martin et al., 2009).  
Finally, ADH catalyzes the breakdown of acetoin to acetyl-CoA. A number of 
microorganisms produce acetoin instead of acetate as an end product of 
fermentation because acetoin is pH neutral and is thus better tolerated at the 
higher concentrations produced by dense cultures (for example at stationary 
phase). When more favorable carbon sources are depleted, acetoin can be 
utilized to form acetyl-CoA (Xiao and Xu, 2007). 
In addition to the five enzyme systems described above, two proteins were 
shown to contain the lipoic acid modification in vivo. The X protein is a 
constituent of the yeast and mammalian PDH and is essential for the assembly of 
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the enzyme complex (De Marcucci and Lindsay, 1985). However, lipoylation of 
the X protein does not seem to be essential for efficient PDH activity. Cui et al. 
reported that a small protein of unknown function in Bacillus subtilis was either 
lipoylated or biotinylated at the same site when expressed in E. coli (Cui et al., 
2006). They referred to this protein as BLAP for biotin/lipoyl acceptor protein. In 
vitro however, BLAP is not lipoylated by any of the Bacillus lipoate-protein ligases 
(Christensen et al., 2011b), and the genomic context of the gene expressing 
BLAP suggests its involvement in a carboxylation reaction and thus favors the 
biotinylation hypothesis (Hanke and Cronan, personal communication). 
PDH, OGDH and GCV are present in E. coli and Sccharomyces cerevisiae, the 
two organisms that are the subject of this thesis. Whether S. cerevisiae also has 
a BCDH is unclear (Dickinson and Dawes, 1992, Hazelwood et al., 2008), 
although the S. cerevisiae membrane does not contain branched-chain fatty 
acids. In yeast all the subunits of PDH, OGDH and GCV are encoded by nuclear 
genes and translocated into the mitochondria. 
Catalytic Function of Lipoic Acid 
With the exception of GCV, the lipoic acid-dependent enzyme systems form 
intricate complexes. The central cores of the complexes are made up of 
multimers of the liopoic acid-containing subunits (E2 subunits) arranged in 
octahedral or dodecahedral formation depending on the complex and the 
organism (Cronan et al., 2005). The cores are surrounded by homodimers of the 
two other subunits: the thiamine pyrophosphate (TPP)-containing E1 subunits 
which carry out the decarboxylation reactions (except for ADH where an 
acetaldehyde group is removed) and the NAD+-containing E3 subunits, the 
dihydrolipoyl dehydrogenases. In most cases the E3 subunits of all the types of 
complexes in the cell are encoded by the same gene (lpd).  
Lipoic acid is covalently attached in amide linkage to the ɛ amino group of a 
conserved lysine of the lipoyl domains (LDs) which protrude from the E2 subunits 
on flexible proline-rich linkers. E2 subunits may contain up to three of these LDs. 
The length and flexible linker of the LDs and their lipoate attachments create an 
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arm that enables translocation of reaction intermediates between the complex 
subunits (Perham, 2000). 
Catalysis at the E1 subunits is initiated when C2 of the thiazole ring of TPP 
donates a proton to solvent forming a carbanion which nucleophilically attacks 
the carbonyl carbon of the incoming 2-oxoacid. This results in breakage of the 
carbon-carbon bond between the carbonyl and the carboxyl carbons of the 
substrate, releasing CO2
2. A double bond now links the substrate to TPP. The 
oxidized sulfur atom (at C8) of lipoic acid electrophilically attacks the double bond 
of the intermediate, carrying away the acyl chain (now one carbon shorter). The 
resulting thioester is finally attacked by the thiol of CoA in the E2 subunit, and 
lipoic acid is reoxidized by Lpd.        
GCV is different from the dehydrogenases in that its subunits do not form a 
stable complex. Lipoate is attached to the GcvH subunit. Decarboxylation is 
carried out at the GcvP subunit which uses pyridoxal phosphate (PLP) as 
cofactor instead of TPP. The carbonyl carbon of PLP forms a Schiff base with the 
glycine amine nitrogen. The sulfur group of lipoic acid attacks the alpha carbon of 
glycine, CO2 is released and the aminomethyl intermediate is carried to the GcvT 
subunit. The aminomethyl is then split into ammonia and a methyl group by two 
consecutive nucleophilic attacks by N5 and N10 of THF. Finally lipoate is 
reoxidized by Lpd. 
Lipoic Acid as a Reductant 
In the complexes described above, lipoic acid functions in an oxidative capacity. 
The two sulfur atoms in the active form of the cofactor are in disulfide linkage. 
Upon completion of a catalytic cycle, the resulting dihydrolipoate (“used” lipoate) 
is reoxidized for a new round of catalysis. The electrons are passed to an FAD+ 
moiety in Lpd and ultimately to NAD+. It is conceivable that the redox cycle would 
run in reverse (Fig. 1.1). In this case dihydrolipoate would act as an electron 
donor in reduction reactions, itself being reduced by Lpd with electrons from 
                                            
2
 In the case of ADH, the carbon-carbon bond between the carbonyl and secondary alcohol 
carbon is broken, releasing acetaldehyde.  
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NADH. Indeed, in 2002 Bryk et al. characterized a peroxiredoxin from 
Mycobacterium tuberculosis, AhpC, which protected the bacterium from host 
peroxides and peroxynitrite. The AhpC reductase was shown to be encoded by a 
gene directly downstream of and likely cotranscribed with ahpC named ahpD. By 
fractionation of M. tuberculosis lysates, Bryk et al. identified Lpd as the reductant 
of AhpD. Purified Lpd required lipoamide (6,8-dithiooctanoic amide; Fig. 1.1) to 
sustain NADH-dependent  AhpD reduction. Thus Bryk et al. proposed the 
formation of a peroxidase complex consisting of AhpC, AhpD, Lpd and SucB (the 
E2 subunit of OGDH and the organism’s sole lipoylated protein) (Bryk et al., 
2002).  
Along similar lines, Cussiol et al. demonstrated that the Ohr (organic 
hydroperoxide resistance protein) of the plant pathogen, Xylella fastidiosa, was 
reduced by lipoate and Lpd as well as LpdA, but not by the 
thioredoxin/thioredoxin reductase (Cussiol et al., 2010). The X. fastidiosa LpdA 
protein is interesting in that it is an Lpd containing its own LD. If indeed lipoic acid 
and Lpd can serve in reductive chemistry, this might enable us to assign function 
to “orphan” Lpd proteins, i.e. lpd-encoding genes in genomes which don’t encode 
any lipoate-dependent enzymes; and/or for the growing class of LpdA proteins 
some of which are also “orphan” (Hakansson and Smith, 2007, Hudson et al., 
2006, Li de la Sierra et al., 1997, Smith et al., 2002).  
The idea of lipoic acid acting as a reductant is corroborated by a recent study by 
Feeney et al. These workers constructed an E. coli strain that is defective in both 
thioredoxin reductase and glutaredoxin reductase (trxB and gor, respectively). 
This strain is unable to grow because the essential enzyme ribonucleotide 
reductase (RNR) is in the nonfunctional oxidized state. Suppressors were 
isolated and mapped to the lpd gene where they resulted in reduced enzyme 
activity. Lpd-defective strains should not be able to grow on glucose minimal 
media because lipoic acid would accumulate in the reduced form, bringing PDH 
and OGDH activities to a halt. However lpd-inactivating mutations in the strain 
background of Feeney et al. were able to grow on glucose minimal. Feeney et al. 
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propose that in the trxB gor lpd strains they studied two pathways were rewired 
into one whereby electrons from reduced lipoate were channeled to the reduction 
of RNR. Using bioinformatics, they further identified a list of organisms whose 
genomes lacked the capacity for glutathione biosynthesis, but did encoded genes 
for glutaredoxins and lipoic acid biosynthesis (Feeney et al., 2011). 
Further support  for the role of lipoic acid in reduction chemistry comes from a 
study of ancient metabolism, which concluded that the original role of lipoic acid 
was to function as a reductant in the CO2 fixation reaction carried out by GCV 
(i.e. the reverse of the process described above) (Braakman and Smith, 2014). 
Braakam and Smith created a metabolic reconstruction of Aquifex aeolicus, one 
of the oldest living species (and an autotroph), based on genome sequence. 
Braakam and Smith found that the genome of the bacterium lacked genes for 
PDH and OGDH, but contained those of GCV and lipoic acid biosynthesis. 
Interestingly the lipoate ligase homologue of A. aeolicus was more similar to the 
Bacillus LipM, which specifically modifies GCV, than to the E. coli LplA which 
modifies the LDs all three enzyme systems (see below). Furthermore, the A. 
aeolicus genome lacks an LipL homologue, which in the case of Bacillus would 
be responsible for modifying PDH, OGDH and BCDH.  
Lipoic Acid Synthesis and Attachment 
Since the initial demonstration, purification and synthesis of lipoic acid (lipoate), 
much has been learned about the synthesis of this essential respiratory co-factor 
in prokaryotes (Cronan, 2008, Cronan et al., 2005) (Fig. 1.2). In E. coli, lipoate is 
assembled on the LD from the eight-carbon fatty acid, octanoate, in two steps. 
First, an octanoyltransferase (LipB) transfers an octanoyl moiety from the acyl 
carrier protein (ACP) of fatty acid synthesis to the LDs (Jordan and Cronan, 
2003, Zhao et al., 2005). A thioester-bound acyl-enzyme intermediate is formed 
in the process (Zhao et al., 2005). Then lipoyl synthase (LipA) catalyzes 
replacement of single hydrogen atoms at carbons 6 and 8 with sulfur atoms, 
using radical SAM chemistry (Booker et al., 2007, Miller et al., 2000). 
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Alternatively, exogenous lipoate or octanoate can be directly attached to LDs by 
lipoate protein ligase (LplA) via an acyl–AMP intermediate.  
Although the LipA sulfur insertion reaction is conserved in all characterized 
lipoate synthesis pathways, there are three well-characterized variations to the E. 
coli pathway in the other reactions. In the lipoate auxotrophic archeon 
Thermoplasma acidophilum, the lipoate protein ligase is composed of two 
separately encoded subunits, LplA and LplB, that together catalyze formation of 
the acyl–AMP intermediate (Posner et al., 2009, Christensen and Cronan, 2009). 
LplB was found to be dispensable for the second half of the reaction, viz. ligation 
of the acyl moiety to the acceptor lysine on the LDs (Christensen and Cronan, 
2009). The Gram-positive bacterium Bacillus subtilis lacks a LipB homologue but 
encodes three LplA homologues, although only LplJ has the ligase function of E. 
coli LplA (Martin et al., 2011). One of the two remaining homologues (LipM) is an 
octanoyltransferase that specifically transfers octanoate from ACP to GcvH 
(Christensen and Cronan, 2010), whereas LipL, the third homologue, is an 
amidotransferase that transfers the octanoyl moiety from GcvH to the LDs of 
PDH, OGDH and BCDH (Christensen et al., 2011b, Martin et al., 2011). LipL is 
also present in Listeria monocytogenes, along with two other LplA homologues 
that are ligases. LplA1 specifically modifies GcvH, whereas the LD specificity of 
LplA2 is undetermined (Christensen et al., 2011a). The lipoate scavenged by L. 
monocytogenes LplAs might come directly from the host environment or might be 
released from host-lipoylated peptides by the action of the lipoamidase(s) 
encoded by this bacterium.  
Octanoyltransferases, amidotransferases and lipoate ligases are difficult to 
distinguish from one another by examination of their amino acid sequences. 
Members of the three groups share minimal amino acid sequence identity yet 
have similar structural folds (Ma et al., 2006, Reche, 2000, Christensen et al., 
2011a). A case in point is LipM, which has the sequence of a lipoate ligase but is 
an octanoyltransferase rather than a ligase (Christensen and Cronan, 2010). 
Whereas octanoyltransferases lack an accessory domain, ligases may contain 
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the accessory domain at either the C-terminus of the same protein such as the 
case with E. coli LplA (Fujiwara et al., 2010, Fujiwara et al., 2005), or at the N-
terminus, such as the case for Streptomyces coelicolor LplA (Cao and Cronan, 
personal communication) (Christensen and Cronan, 2009), or the accessory 
domain may be encoded by a completely separate gene, such as the T. 
acidophilum LplB (McManus et al., 2006, Posner et al., 2009, Christensen and 
Cronan, 2009). 
The diversity in prokaryotic lipoate attachment mechanisms is surprising given 
the simple structure of the coenzyme. The situation in eukaryotes is not well 
understood, and may contribute further enzymatic diversity. In yeast, fungi, plant 
and animal cells, lipoate-dependent enzyme systems as wells as lipoate 
synthesis enzymes are targeted to the mitochondria. Additionally plant 
chloroplasts contain PDH. Work from the Wada lab has shown that Arabidopsis 
thaliana contains two LipA enzymes, one targeted to mitochondria, the other to 
chloroplasts (Yasuno and Wada, 2002, Wada et al., 2001). The A. thaliana 
genome encodes three LipB/LplA-type enzymes; one for each of the 
mitochondria and the chloroplasts and the third is still under study (Yasuno and 
Wada, 2002). Since the plant cellular compartments are expected to contain 
acyl-ACPs (and thus octanoyl-ACP), but no free fatty acids or lipoate, it may be 
postulated that the LipB/LplA enzymes characterized thus far are 
octanoyltransferases, although no enzymology has been conducted to confirm 
this. On another front, Kang et al. cloned a gene from Oryza sativa which 
complemented an E. coli lipB lplA strain both in the presence and absence of 
exogenous lipoate (although in liquid culture complementation was better in the 
absence of lipoate) (Kang et al., 2007). This enzyme merits further study.   
In apicomplexan parasites, PDH is located in the plastid-derived organelle called 
the apicoplast, while all other lipoate-depended systems localize to the singular 
mitochondrion of the cell (Thomsen-Zieger et al., 2003). Additionally the 
apicoplast contains a type II fatty acid biosynthetic pathway complete with an 
ACP (Thomsen-Zieger et al., 2003). It is therefore not surprising that enzymes of 
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endogenous lipoate synthesis, LipA and LipB, are found exclusively in 
apicoplasts (Wrenger and Muller, 2004). Inhibiting apicoplast fatty acid 
biosynthesis or knocking out the apicoplast ACP encoding gene eliminates 
lipoate biosynthesis in the organelle (Crawford et al., 2006). One of the two LplAs 
found in these organisms, LplA1, is targeted to the mitochondria (Allary et al., 
2007). Gunther et al. showed that LplA1 is essential for Plasmodium falciparum, 
whereas LipB is not (Gunther et al., 2007). LipB is probably dispensable because 
of the presence of a second LplA, LplA2, which is targeted to both apicoplasts 
and mitochondria (Gunther et al., 2007). However the exact enzymatic nature of 
LplA2 remains unclear. It seems that LplA2 is an amidotransferase since labeling 
studies conducted by Allary et al. with radioactive lipoate showed labeling of 
mitochondrial proteins but not the apicoplast PDH (Allary et al., 2007); i.e. LplA2 
was not able to utilize free lipoate. LplA2 merits more study, especially since the 
LplA2 of Toxoplasma gondii seems strikingly different from that of P. falciparum 
at least at the amino acid sequence level (Gunther et al., 2009).     
Early studies of the bovine LplA homologue (LipT; for lipoyltransferase) 
demonstrated that the enzyme was unable to form the acyl–AMP intermediate 
(Fujiwara et al., 1994). However, LipT was able to transfer the acyl chain from 
exogenously provided acyl–AMP to LDs in vitro, giving rise to the proposal that 
mammalian lipoate attachment requires a ‘lipoate-activating enzyme’. 
Accordingly, Fujiwara et al. purified an enzyme from bovine liver that synthesized 
lipoyl-GMP in vitro, which in turn could be utilized by LipT to modify LDs 
(Fujiwara et al., 2001). However, this putative lipoate-activating enzyme is one of 
many poorly characterized medium-chain fatty acyl–co-enzyme A (CoA) ligases 
that have extremely broad substrate specificities (Kasuya et al., 2006, Vessey et 
al., 2000) and thus the physiological relevance of its in vitro lipoyl-GMP-forming 
activity is unclear. 
Studies by Schonauer et al. (2009) on the yeast S. cerevisiae showed that Lip2, 
Lip5, Lip3 (the LipB, LipA and LplA homologues respectively) as well as Gcv3 
(the GcvH homologue) are all required for endogenous lipoate synthesis and 
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attachment (Schonauer et al., 2009). Respiratory growth of a lip2 strain, which 
contains a wild type copy of the lip3 gene, is not supported by exogenous lipoate 
supplementation (Chen, 1997, Marvin et al., 2001), suggesting that S. cerevisiae 
lacks a lipoate scavenging pathway. On the other hand, early studies by Sulo 
and Martin (Sulo and Martin, 1993) showed that even though lipoate did not 
support the respiratory growth of lip5 strains, the cells contained a substantial 
level of protein-bound lipoate when grown on lipoate-supplemented media, 
suggesting the presence of a scavenging mechanism in S. cerevisiae.  
Genetic Diseases Caused by Lipoic Acid Synthesis Defects 
The number of genetic disorders with recognized causation related to 
mitochondrial function and specifically PDH, OGDH and GVC function is growing. 
Only one human case of a genetic defect in a lipoic acid synthesis gene has 
been reported to date. A boy with a homozygous point mutation in the lipA gene 
suffered epileptic seizures starting at two days of age. His condition progressively 
worsened as he developed muscular hypotonia, lactic acidosis, elevated glycine 
concentrations in blood and urine, respiratory deficiency, and lung inflammation. 
The boy eventually died of a severe respiratory tract infection at age four (Mayr 
et al., 2011).  
Genetic manipulations of mice have offered more insight into the central role 
played by lipoic acid in health. In 2005 Yi and Maeda were able to inactivate the 
lipA gene in mice embryonic stem cells. Unlike in the human case reported 
above, none of the homozygous null mutants survived to birth. Supplementing 
the mothers’ diets during pregnancy with up to 1.65 g/kg body weight of lipoic 
acid failed to prevent prenatal death, suggesting that endogenous synthesis of 
lipoic acid is essential at least during development in mice (Yi and Maeda, 2005).  
A similar yet more extensive study was conducted by Smith el al. (2012) who 
knocked out the gene encoding mitochondrial malonyl CoA:ACP transacylase 
(Mcat)  in mice. The reaction catalyzed by Mcat initiates mitochondrial fatty acid 
biosynthesis which produces the octanoyl moiety from which lipoate is 
synthesized. Smith et al. observed a plethora of phenotypic changes in the 
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knockout mice compared to wild type controls amongst which were weight loss 
despite higher food consumption, hypothermia, anemia, lactic acidosis and 
reduced stamina. Closer examination revealed compromised mitochondrial 
function probably due to the observed reduction in lipoylated proteins. Finally by 
Western blot analysis Smith et al. also found that LipT is primarily expressed in 
liver tissue (Smith et al., 2012), which could explain why lipoic acid diet 
supplements were not useful in the Yi and Maeda study 
Specific Aims of This Work 
There are two parts to this project. In the first part, I studied an E. coli ∆lipB 
mutant strain. This strain is defective in endogenous lipoic acid synthesis and 
thus its aerobic growth on glucose minimal media is strictly dependent on 
supplementation with either lipoate (or octanoate), or acetate plus succinate 
which respectively bypass the PDH- and OGDH-catalyzed steps required for 
TCA cycle function (Herbert and Guest, 1968). I isolated ∆lipB suppressor 
strains. Initial characterization distinguished two types. In one type (discussed in 
Chapter 2) the mutations causing suppression of the ∆lipB defect were mapped 
to the lplA locus. In the second type (discussed in Chapter 3), the causative 
mutation mapped to the sdhB gene, which encodes a subunit of succinate 
dehydrogenase. 
In the second part of this project I sought to further investigate the role of the 
lipoate-protein ligase homologue, Lip3, in lipoic acid synthesis in S. cerevisiae. In 
Chapter 4, I show that Lip3 has octanoyl-CoA: protein transferase activity and 
present a model for lipoic acid synthesis in S. cerevisiae.  
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Figures 
 
Figure 1.1: Structure of lipoic acid and its precursor. The eight-carbon fatty 
acid, octanoate (1), is the precursor of lipoic acid (2). Lipoic acid undergoes 
redox cycling between the oxidized (2) and reduced dihydrolipoate (3) forms. 
Lipoamide (4) mimics the structure of lipoic acid in amid linkage.  
  
14 
 
 
Figure 1.2: Diversity of lipoate attachment mechanisms.  In the biosynthetic 
pathways (dashed box), octanoyl-ACP (1) is extracted from the pool of fatty acid 
biosynthesis intermediates by an octanoyltransferase (LipB in E. coli, LipM in B. 
subtilis, or Lip2 in S. cerevisae) which transfers the octanoyl moiety to the LDs 
(e.g., that of the glycine cleavage system; black box). This is followed by sulfur 
insertion by a lipoate synthase (designated LipA in prokaryotes and Lip5 in S. 
cerevisiae). The LipL amidotransferases transfer the lipoyl moiety from lipoyl-
GCV (3) to pyruvate dehydrogenase (white box), 2-oxoglutarate dehydrogenase 
and the branched chain oxoacid dehydrogenase (not shown). In the scavenging 
pathways, free lipoic acid (5) is directly ligated onto the LDs by a lipoate-protein 
ligase (LplA of E. coli, LplJ of B. subtilis or the LplA/B complex of T. acidophilum). 
This figure is from (Hermes and Cronan, 2013). 
 
  
15 
 
Chapter 2: Scavenging of Cytosolic Octanoic Acid by Mutant 
LplA Lipoate Ligases Allows Growth of Escherichia coli Strains 
Lacking the LipB Octanoyltransferase of Lipoic Acid Synthesis3 
 
Introduction 
Escherichia coli has three lipoic acid-dependent enzyme systems; pyruvate 
dehydrogenase (DPH), 2-oxoglutarate dehydrogenase (OGDH), and the glycine 
cleavage system (GCV) (Cronan et al., 2005). PDH catalyzes the oxidative 
decarboxylation of pyruvate to acetyl-CoA, the tricarboxylic acid (TCA) cycle 
substrate and fatty acid building block. OGDH functions in the TCA cycle where it 
catalyzes the decarboxylation of 2-oxoglutarate to succinyl-CoA, the precursor of 
several amino acids. GCV is involved in the breakdown of glycine into ammonia 
and C1 units. Whereas GCV is expressed only in the presence of glycine, PDH 
and OGDH are required for aerobic growth. (During anaerobic growth acetyl-CoA 
is synthesized by other enzymes and an OGDH-independent branched form of 
the TCA cycle forms succinyl-CoA from succinate.) The three enzyme systems 
contain subunits (the E2 subunits of PDH and OGDH, and the H protein of GCV) 
which contain at least one lipoyl domain, a conserved structure of ca. 80 residues 
(Cronan et al., 2005). Lipoic acid is attached in an amide bond to a specific lysine 
residue of these domains where it functions as a classical “swinging arm”, 
carrying reaction intermediates between the active sites of the lipoate-dependent 
systems (Perham, 2000). 
Lipoic acid (R-5-(1,2-dithiolan-3-yl)pentanoic acid, also called 6,8-dithiooctanoic 
acid and thioctic acid) is composed of an eight carbon fatty acid backbone to 
which two sulfur atoms are attached at carbons 6 and 8 (Fig. 2.1). In the oxidized 
state, the sulfur atoms are in disulfide linkage forming a five-membered ring with 
                                            
3 Results presented in this chapter are published in the Journal of Bacteriology 
(2009) 191(22):6796-803. 
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three backbone carbons. The disulfide bond is reduced upon binding of the 
intermediates (an acetyl moiety in the case of PDH, a succinyl moiety in the case 
of OGDH and an aminomethyl moiety in the case of GCV). Following release of 
the intermediates to form the products of the enzyme complexes, the reduced 
lipoyl moiety must be reoxidized before entering another catalytic cycle. 
Oxidation is catalyzed by lipoamide dehydrogenase, a subunit component of the 
three lipoic acid-dependent enzyme systems (Cronan et al., 2005). E. coli strains 
defective in lipoic acid biosynthesis are unable to grow on aerobic glucose 
minimal media unless the media are supplemented with acetate and succinate to 
bypass the need for the two lipoic acid-dependent dehydrogenases (Herbert and 
Guest, 1968, Perham, 2000). 
Studies in our laboratory and others’ have elucidated the lipoic acid synthesis 
pathway of E. coli (Fig. 2.1). The LipB octanoyl-[acyl carrier protein]:protein N-
octanoyltransferase (Jordan and Cronan, 2003, Zhao et al., 2003, Zhao et al., 
2005) transfers the octanoyl moiety from octanoyl-acyl carrier protein (ACP), a 
fatty acid biosynthetic intermediate to lipoyl domains. This reaction proceeds 
through an acyl enzyme intermediate in which the octanoyl moiety is in thioester 
linkage to a conserved cysteine residue in the enzyme active site (Ma et al., 
2006, Zhao et al., 2005). The thioester bond is then attacked by the -amino 
group of the target lipoyl domain lysine residue to give the amide linked lipoate 
moiety. The product of this catalysis, octanoyl-domain, is the substrate of the 
LipA lipoate synthase, an S-adenosylmethionine radical enzyme which inserts 
sulfur atoms at carbons 6 and 8. In addition to the LipB-LipA pathway of lipoic 
acid synthesis, E. coli also contains an enzyme that scavenges lipoic acid from 
the growth medium, the LplA lipoate:protein ligase. LplA uses ATP to activate 
lipoic acid to lipoyl-adenylate, the mixed anhydride of which is attacked by the 
lipoyl domain lysine reside to give the lipoylated domain (Fig. 2.1). LplA is also 
active with octanoic acid and efficiently attaches exogenous octanoate to lipoyl 
domains both in vivo and in vitro (Green et al., 1995, Morris et al., 1995, Zhao et 
al., 2003, Morris et al., 1994). Null mutants in lplA have no phenotype in strains 
having an intact lipoic acid synthesis pathway (Morris et al., 1995) 
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The subject of this report is the behavior of lipB null mutants which (as expected 
from the above discussion) are lipoic acid auxotrophs (Morris et al., 1995, 
Vanden Boom et al., 1991). Growth of lipB strains can also be supported by 
octanoate supplementation of the medium (Zhao et al., 2003). Upon plating of 
lipB null mutants on minimal glucose medium, colonies arise that no longer 
require lipoic acid (Morris et al., 1995). These are suppressor mutations because 
the block in lipoic acid synthesis remains. Suppression in the strains studied in 
this work maps to the lplA gene.The LplA proteins encoded by these suppressor 
mutants are point mutations that greatly decrease the Michaelis constant for free 
octanoic acid and allow efficient scavenging of cytosolic octanoate. 
Materials and Methods 
Bacterial strains and plasmids:  
Strains used in this study (Table 2.1) are derivatives of E. coli strains MG1655 
and W3110. Transduction using phage P1vir and transformation were conducted 
following conventional methods (Miller, 1992). Strain FH6 was made by 
transducing strain MG1655 to kanamycin resistance with a P1 phage stock 
grown on strain KER184. Strains FH26 and FH27 were isolated by plating strain 
FH6 on glucose minimal plates followed by incubation of the plates for 2-3 days 
at 370C. The tetracycline resistance marker of transposon Tn10 was introduced 
upstream of the lplA gene in strains FH26 and FH27 by transduction with a P1 
phage stock grown on strain CAG18430 (Singer et al., 1989) to give strains FH66 
and FH35 respectively. The lplA genes of FH66 and FH35 were transferred into 
strain ZX221 by P1 transduction followed by screening for growth on glucose 
minimal plates in the absence of supplementation. The resulting strains were 
designated strains FH145 and FH146, respectively. Strains FH46 and FH47 were 
made by transducing the tetracycline resistance marker from TM135 into strains 
FH26 and FH27, respectively, with selection on LB plates supplemented with 
succinate and acetate. Strains FH57 and FH58 were obtained by transducing 
FH26 and FH27 with a P1 phage stock grown on KER310 with selection on LB 
plates supplemented with lipoic acid, kanamycin and tetracycline.  
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Plasmids pFH1 and pFH2 which, respectively, express the S221P and V19L 
LplAs under control of an IPTG inducible promoter were made by site directed 
mutagenesis of plasmid pYFJ16 by the QuikChange procedure (Stratagene).  
Media and growth conditions:  
Luria-Bertani and minimal E media were prepared as described (Miller, 1992). 
Supplements were added at the following concentrations: glucose, 0.4%; 
glycerol, 0.4%; succinate, 5 mM; acetate, 5 mM; and lipoic acid, 7.5 ng/ml. 
Antibiotics were used at the following concentrations (in µg/ml) ampicillin, 100; 
spectinomycin, 100; tetracycline, 15; kanamycin, 50 and chloramphenicol, 20. 
The growth temperature was 370C. 
DNA extraction, PCR and sequencing:   
DNA was extracted using the Promega Wizard Genomic DNA Purification Kit. 
PCR was conducted using either Taq (New England Biolabs) or Pfu (Invitrogene) 
DNA polymerases and appropriately designed primers per manufacturers’ 
recommendations. DNA sequencing was conducted by the Core Sequencing 
Facility of the Carver Biotechnology Center of the University of Illinois, Urbana 
Champaign. 
Assays of PDH and OGDH activities:  
A method similar to that of (Guest and Creaghan, 1973) was used. Cultures were 
grown to late exponential phase in 100 ml of glucose minimal media 
supplemented with succinate and acetate. The cells were then collected by 
centrifugation, washed twice with 10 ml of 150 mM Tris-HCl buffer (pH 8.5), 
frozen in a dry ice-ethanol bath and stored overnight at -20 0C. The next day the 
cell pellet was thawed on ice. The cells were suspended in 1 ml of 150 mM Tris-
HCl buffer (pH 8.5) per mg wet cell weight and lysed by passage twice through a 
French Press cell at 1000 psi. The crude extract was collected on ice, cleared by 
centrifugation and the protein concentration determined by the BioRad Bradford 
assay (Bradford, 1976) using a standard curve of bovine serum albumen. Crude 
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extract protein preparations (100-300 µg) were added directly to cuvettes 
containing the assay reaction mixture consisting of 150 mM Tris-HCl buffer 
(pH8.5), 3 mM L-cysteine hydrochloride as reducing agent, 0.1 mM CoA and 5 
mM thiamine pyrophosphate in a 500 µl volume.  PDH assay mixtures also 
contained 5 mM MgCl2. 3-Acetylpyridine adenine dinucleotide (APAD; Sigma-
Aldrich) was then added to a final concentration of 2 mM, and the mixture 
allowed to equilibrate at room temperature for 15 min. The reaction was started 
by adding either 5 mM pyruvate (PDH activity) or 5 mM 2-oxoglutarate (OGDH 
activity). Increased absorption at 366 nM corresponding to reduction of APAD 
was monitored for 5 min in a Beckman DU640 spectrophotometer. The activities 
of the complexes were calculated in the range of linearity between initial reaction 
velocity and protein concentration. The extinction coefficient of the reduced form 
of the cofactor used in the calculation was 7.0 nM-1 cm-1 (Christensen and 
Cronan, 2009).  
Detection of in vivo lipoation by western blotting:  
Strains carrying plasmid pGS331 which encodes a hybrid PDH lipoyl domain 
under control of the tac promoter (Ali and Guest, 1990) were cultured to late 
exponential phase in 15 ml of glucose minimal media supplemented with 
succinate, acetate, ampicillin and IPTG (1 mM), with or without octanoic acid (50 
µM). The cells were collected, washed twice with 1 ml of 20 mM Tris-HCl (pH 
7.5) and stored at -20 0C overnight. The following day the pellet was thawed on 
ice and resuspended in 500 µl of the same buffer. The cells were lysed in a 
Misonix sonicator (two 5 min intervals with 1 min cooling in between). The extract 
was cleared by centrifugation and protein concentration determined as above. A 
20% native polyacrylamide gel was loaded with 100 µg of extract protein and 
following electrophoresis the proteins were then transferred to a PVDF 
membrane using a standard protocol (Ausubel et al., 2007). Lipoylated domain 
was detected using rabbit anti lipoyl protein primary antibodies from Calbiochem 
and goat anti rabbit antibody from Roche.  
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Protein expression and purification:  
Hexahistidine-tagged (N-terminal) versions of the wild type, V19L and S221P 
LplAs were purified using Qiagen nickel nitrilotriacetic acid columns as 
recommended by the manufacturer. Contaminants which copurified with the 
proteins were removed using a modification of a prior procedure (Green et al., 
1995). The proteins were adsorbed to a Vivapure Maxi H type Q columns 
equilibrated with 20 mM Tris-HCl buffer (pH 7.5) containing 1 mM EDTA, 10% 
glycerol and 0.1 mM phenylmethanesulfonylfluoride. The LplA proteins were 
eluted with the same buffer containing 120 mM ammonium sulfate. Protein 
concentrations were measured by absorbance at 280 nm using a molar 
extinction coefficient of 46250 M-1 cm-1 (Green et al., 1995) 
Apo-lipoyl domain was expressed from pGS331 in strain QC146 and purified by 
a modification of the method of Ali and Guest (Ali and Guest, 1990). After titration 
of the pH of the crude extract to 4 and centrifugation, the pH of the supernatant 
was increased to 7 with 1 M NaOH. The extract was dialyzed overnight against 
10 mM ammonium acetate buffer (pH 5) and then subjected to anion exchange 
chromatography on a POROS HQ column eluted with a 10-600 mM ammonium 
acetate gradient at pH 5. Protein concentrations were determined at 280 nm 
using a molar extinction coefficient of 2020 M-1 cm-1 (Ali and Guest, 1990). 
Holo-acyl carrier protein (ACP) was expressed and purified from strain DK574 
carrying plasmid pJT93 as described by Cronan and Thomas (2009). Histidine 
tagged V. harveyi acyl-ACP synthase was expressed from strain YFJ239 and 
purified using Qiagen nickel nitrilotriacetic acid columns as recommended by the 
manufacture. Octanoyl-ACP was synthesized as described by Cronan and 
Thomas (Cronan and Thomas, 2009). 
Gel shift assay of LplA activity:  
A 20 µl reaction mixture contained 10 mM sodium phosphate buffer (pH 7), 0.3 
mM dithiothreitol, 30 µM apo-lipoyl domain and 5 µM enzyme. When checking for 
ligase activity, 5 mM MgCl2, 5 mM ATP and various concentrations of lipoic acid 
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or octanoic acid were added. Alternatively, to assay octanoyltransferase activity 
octanoyl-ACP was added in place of ATP and octanoate/lipoate. The reactions 
were run for 2 h at 37 0C after which 10 µl was loaded on a 20% polyacrylamide 
gel containing 2.5 M urea and separated by electrophoresis. 
Filter disk shift assay of LplA activity:  
The reaction mixture was the same as that used in the gel shift assay except that 
the assay contained varying concentration of [1-14C]octanoic acid. After 
equilibration at 370C, a sample was removed as a no enzyme control and 
enzyme added to a final concentration of 100 nM, which was determined to be 
within the range of linear activity with respect to enzyme concentration under 
these conditions (data not shown). Samples (15µl) were removed every 3 min for 
15 min and spotted onto 2.3 mm diameter Whatman filter disks which had been 
presoaked in 5% trichloroacetic acid and dried. The disks were then dried and 
washed three times (10 min each wash) with a solvent mixture containing 
chloroform-methanol-acetic acid (3:6:1). After a final wash with absolute ethanol 
the disks were dried, added to vials containing 4 ml of scintillation cocktail, and 
counted in a Beckman Coulter LS 6500 scintillation counter (Jiang and Cronan, 
2005). The data were analyzed using the Prism analysis program and Km and 
Vmax values were determined by the Edie-Hofstee method (Hofstee, 1952). 
Fatty acid extraction and butyl ester synthesis:  
Strain FH213 was grown in one liter of glycerol minimal media containing 
spectinomycin and ampicillin. When the culture reached stationary phase, IPTG 
was added to a final concentration of 1 mM and induction was allowed to 
proceed for 3 h. The cells were then collected and lysed by freezing in a dry ice-
ethanol bath then thawed at room temperature. Fatty acids were converted to 
their sodium salts by mixing the cell extract with 0.1 M sodium bicarbonate 
overnight at 40C, after which the solution was acidified to pH 3 with glacial acetic 
acid and 3 ml hexane was added. After 1 h of stirring at 40C, the fatty acid-
containing organic phase was collected and transferred to a 5 ml glass vial with a 
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plastic stopper. Heptanoic acid (1µg) was added to serve as internal standard. 
Butyl ester synthesis was conducted in a manner similar to Hallmann et al. 
(Hallmann et al., 2008). Butanol/BF3 (0.1 ml) and 1 gm of anhydrous sodium 
sulfate were added, the vial was sealed with Parafilm followed by incubated in a 
650C heating block for 2 h. The reaction was then cooled to room temperature. 
The solution was washed three times with 3 ml distilled water and concentrated 
under nitrogen gas to 100 µl of which 5 µl was analyzed by gas chromatography-
mass spectrometry (GC-MS). Samples (5 µl) were injected in splitless mode to 
the GC/MS system consisting of an Agilent 6890N gas chromatograph, an 
Agilent 5973 mass selective detector and HP 7683B (Agilent Inc, Palo Alto, CA, 
USA) autosampler. Injections were performed on a 30 m HP-5MS column with 
0.25 mm I.D. and 0.25 µm film thickness (Agilent Inc, Palo Alto, CA, USA) with 
an injection port temperature of 2500C, the interface set to 2500C, and the ion 
source adjusted to 2300C. The helium carrier gas was set at a constant flow rate 
of 1 ml min-1. The temperature program was 1 min isothermal heating at 400C, 
followed by an oven temperature increase of 50C min-1 to 1800C for 1 min. The 
mass spectrometer was operated in positive electron impact mode (EI) at 69.9 
eV ionization energy in m/z 50-550 scan range. The spectra of all chromatogram 
peaks were evaluated using the HP Chemstation (Agilent, Palo Alto, CA, USA) 
and AMDIS (NIST, Gaithersburg, MD, USA) programs.  
Random mutagenesis of lplA:  
The lplA gene was PCR amplified from FH6 with primers lplAfor and lplArev 
(Table 2.1) that are complementary to regions about 150 nucleotides upstream 
and downstream of the coding region, respectively. The PCR product was 
purified using the Qiagene PCR cleanup kit then subjected to either 12 or 35 
cycles of error prone PCR (Ausubel et al., 2007). The mutagenized products 
were electroporated into FH6 expressing the λ Red recombinase system 
(Datsenko and Wanner, 2000). The cells were allowed to recover in glucose 
minimal medium supplemented with succinate and acetate for 90 min at 37 0C. 
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The cells were collected, washed three times with minimal medium and plated on 
glucose minimal plates.  
Results 
Suppression in strains FH26 and FH27 requires lipA and is due to point 
mutations in the lplA coding region.   
Strain FH6 (a lipB knockout) is blocked in the first step in lipoyl protein synthesis 
and thus it lacks active PDH and OGDH complexes (Morris et al., 1995). 
Consequently, the strain is unable to grow aerobically on glucose minimal 
medium unless supplemented with either lipoic or octanoic acid which LplA 
attaches to PDH and OGDH (Morris et al., 1995). Growth also occurs when the 
medium is supplemented with acetate and succinate which bypass the enzymatic 
steps catalyzed by PDH and OGDH, respectively. Strains FH26 and FH27 were 
isolated as suppressors of the lipB null mutation in strain FH6 that grew on 
unsupplemented glucose minimal media. Introduction of a lipA null mutation into 
strains FH26 and FH27 (to give strains FH57 and FH58, respectively) by 
transduction resulted in loss of the ability to grow on glucose minimal media. 
These results indicated that suppression was caused by a pathway that resulted 
in octanoylation of PDH and OGDH. Previous work suggested that in vitro LplA 
has weak octanoyl transferase activity (Jordan and Cronan, 2003) and showed 
that overproduction of LplA alleviates the growth defect of lipB null mutants 
(Morris et al., 1995). We therefore asked if the growth of strains FH26 and FH27 
was mediated by LplA. Two observations supported this hypothesis. First, 
transductional introduction of an lplA null mutation into strains FH26 and FH27 
(to give strain FH46 and FH47, respectively) resulted in lack of growth on 
unsupplemented glucose minimal medium. Second, transductional backcrossing 
of the lplA genes (and linked regions) from strains FH26 and FH27 into a lipB 
knockout strain (to give strains FH145 and FH146, respectively) conferred the 
ability to grow on glucose minimal medium.  
These data suggested two straightforward hypotheses for the observed 
octanoylation mediated by the mutant lplA alleles of strains FH26 and FH27. 
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First, the lplA-linked mutations may result in overexpression of LplA which is 
known to suppress the lipB phenotype (Morris et al., 1995). The second 
hypothesis was that the mutations were actually in the lplA coding region and 
resulted in mutant LplA proteins which catalyze octanylation more efficiently than 
does the wild type protein. This could be due to an increase in the putative 
octanoyltransferase activity of LplA or to a heretofore unrecognized pathway. To 
test these hypotheses the lplA genes and upstream regions of the strains FH26 
and FH27 chromosomes were PCR amplified and the amplification products 
were sequenced. Both strains were found to carry a missense mutation within the 
lplA coding sequence. The lplA gene of strain FH26 contained a G58C point 
mutation which results in a V19L amino acid substitution (referred to here as 
lplA10) whereas strain FH27 contained a T664C point mutation that gives rise to 
a S221P amino acid substitution (referred to as lplA11). 
The suppressor strains contain active lipoylated PDH and OGDH 
complexes.  
The PDH and OGDH complexes contain essential lipoate-dependent subunits 
and thus their activities indicate in vivo lipoylation. We assayed the strains 
carrying either the lplA10 (strain FH145) or the lplA11 (strain FH146) alleles for 
PDH and OGDH activities in cells from cultures grown on glucose minimal 
medium supplemented with succinate and acetate. Both mutant strains had 
levels of PDH and OGDH activities similar to those of strain JK1, the wild type 
parental strain, whereas the activities of the isogenic lipB null mutant strain 
ZX221 were near background (Fig. 2.2). These data indicated that the LplA 
proteins encoded by strains FH145 and FH146 were able to activate the PDH 
and OGDH complexes.  
In a second approach we expressed a PDH lipoyl domain in various strains 
grown on glucose minimal medium supplemented with succinate and acetate and 
asked whether or not the domain became lipoylated. Since all of the strains 
contained a functional LipA lipoyl synthase, any octanoyl-domain formed would 
be converted to lipoyl-domain which could be detected by western blotting with 
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anti-lipoate antibody (the antibody does not recognize octanoyl-domains, Q. 
Christensen and J. E. Cronan, unpublished data). When the medium was 
supplemented with octanoic acid (Fig. 2.3B), the wild type strain, a lipB null strain 
and the two strains with mutant lplA genes (FH145 and FH146, lanes 5 and 6) 
accumulated lipoylated domain because these strains contained active LplA 
which catalyzed attachment of exogenous octanoic acid to the unmodified 
domain where it was converted to lipoate by LipA. Likewise an lplA strain also 
accumulated lipoylated domain due to LipB function. In contrast strains FH145 
and FH146 grown in the absence of octanoic acid supplementation contained 
detectable levels of domain modified with lipoate whereas the lipB strain did not 
(Fig. 2.3A). These data indicated that the suppressor strains were able to attach 
octanoate to the lipoyl domain in the absence of exogenous octanoic acid. (The 
modified domains of the wild type and lplA strains resulted from LipB activity). 
The mutant LplA proteins efficiently scavenge octanoic acid.   
As stated earlier, previous work has suggested that LplA utilizes octanoyl-ACP 
(Jordan and Cronan, 2003, Zhao et al., 2003). To test the utilization of octanoyl-
ACP we purified histidine-tagged versions of wild type, V19L and S221P LplA 
proteins and tested their octanoyltransferase activity using the gel shift assay. In 
this assay an unmodified hybrid lipoyl domain is provided as substrate along with 
octanoyl-ACP (Zhao et al., 2005). Attachment of octanoic acid to the appropriate 
lysine residue on the lipoyl domain results in loss of a positive charge which 
causes the domain to migrate more rapidly than the unmodified protein in native 
gel electrophoresis. In our initial experiments, we observed activity with V19L and 
S221P LplAs, but not with wild type LplA using as substrate octanoyl-ACP 
preparations purified by precipitation and washing of the precipitate. However, 
although octanoylated domain was synthesized, we did not see the expected 
concomitant release of holo-ACP. We subsequently found that use of 
preparations of octanoyl-ACP that were extensively dialyzed following acyl-ACP 
synthetase-catalyzed synthesis of octanoyl-ACP to remove excess octanoic acid, 
ATP and MgCl2 gave no activity with the LplA proteins whereas the preparations 
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were active with LipB (Fig. 2.4). These results indicated that the mutant LplAs did 
not utilize octanoyl-ACP, but rather used the traces of free octanoic acid, ATP 
and MgCl2 that remained in the octanoyl-ACP preparations purified by 
precipitation and washing. The fact that we observed a reaction with the mutant 
LplA proteins, but not with the wild type LplA was the first indication that the 
mutant LplA proteins may have reduced Km values for one of the substrates, 
probably octanoate. This was confirmed by assaying [1-14C]octanoic acid 
attachment to lipoyl domains by the filter disk assay (Materials and Methods) 
(Table 2.2). The two mutant LplAs had Km values for octanoate that were 50 (the 
S221P mutant) or 20-fold (the V19L mutant) lower than that of the wild type 
enzyme. The mutations also decreased the Vmax values of the two enzymes with 
the S221P protein showing a decrease of 10-fold. 
E. coli contains free octanoic acid.  
The multiple lines of evidence obtained both in vivo and in vitro indicated that the 
mutant LplA proteins must suppress lipB null mutants by utilizing cytosolic 
octanoic acid. This argued that there must be an intracellular pool of this fatty 
acid, although there were no data in the literature to support this premise. 
Intracellular pools of short chain free fatty acids, such as octanoate had not been 
reported in E. coli, but this could readily be explained by the slight solubility of 
octanoic acid in water (ca. 0.7 g/L) plus the volatility of the acid and especially of 
its methyl ester, the most commonly analyzed derivative. To test for the presence 
of octanoate we first trapped the short chain acids as their non-volatile sodium 
salts and then converted the salts to the butyl esters which are much less volatile 
than the methyl esters.  
Free fatty acids were extracted from wild type cells grown in glycerol minimal 
medium carrying the lysis plasmid pJH2 used in order to allow gentle disruption 
of the cellular membrane (Crabtree and Cronan, 1984). After lysis the fatty acids 
were converted to their sodium salts and subsequently acidified to break down 
the salts and allow extraction of the acids into hexane. Heptanoic acid (1µg) was 
added as an internal standard and the fatty acids were esterified with butanol in 
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the presence of acid (BF3). The butyl esters were detected by GC-MS (Fig. 2.5). 
A total of 712 ng of octanoic acid was extracted from one liter of cells (about 1.18 
x 1012 cells). Interestingly, decanoic acid was also detected (Fig. 2.5). Since 
quantitative extraction and derivatization could not be assumed we determined 
the efficiency of our extraction by spiking an extract with [1-14C]octanoic acid. 
One liter of cells was grown, collected and lysed as above. [1-14C]Octanoic acid 
was added to the extract and the usual extraction procedure was followed as 
described in Materials and Methods. After the final step (concentration under N2), 
the extracted [1-14C]octanoic acid radioactivity was determined by a scintillation 
counting. Only 17% of the initial radioactivity was recovered. In a separate 
experiment we determined the efficiency of the butyl ester formation and found it 
to be quantitative.  
Other mutant LplA proteins that suppress a lipB null allele.  
The lplA gene was randomly mutagenized by error prone PCR. The PCR 
products were transformed into strain FH6 expressing the λ Red recombinase 
system enzymes (Datsenko and Wanner, 2000). After recovery the cells were 
plated on glucose minimal media without supplementation. A total of 13 colonies 
were isolated and the lplA gene from each of these colonies was PCR amplified 
cloned into pCR2.1 TOPO cloning vector and sequenced. Four isolates had the 
same point mutation as the V19L LplA. Another had the same point mutation as 
the S221P mutation and two isolates had no mutations within the coding 
sequence. The remaining six isolates had lplA genes containing multiple point 
mutations (Table 2.3). 
Discussion 
In this work we isolated and studied two spontaneously arising lipB suppressor 
strains and determined that suppression was caused by single point mutations in 
the LplA protein which reduce the Km for free octanoic acid. The V19L mutation 
resulted in a 20-fold decrease in the Km for octanoic acid whereas the S221P 
mutation resulted in a 50-fold decrease. Since the suppressor strains grew and 
formed lipoyalated proteins in the absence of octanoic acid supplementation, an 
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in vivo synthesized pool of free octanoic acid must be present in E. coli. Indeed 
we were able to extract 712 ng of free octanoic acid from the cells of a 1 L 
culture. Taking the cell volume as 0.88 x 10-15L (www.ecocyc.org) and correcting 
for the low efficiency with which we extracted octanoic acid from cell extracts 
(17%), this indicates an intracellular octanoate concentration of about 28.2 µM. 
This intracellular concentration is well above the Km values of the V19L and 
S221P LplA enzymes, but 7.6-fold lower than the Km value of wild type enzyme. 
Hence, lipB strains encoding mutant LplAs (either the V19L or the S221P 
proteins) are able to synthesize lipoylated proteins (Fig. 2.3) and thus active PDH 
and OGDH complexes (Fig. 2.2). It is important to note however that despite the 
benefit gained in these mutant LplAs in terms of reducing the Km for octanoate, 
this was not without consequence; both enzymes had decreased Vmax values. 
This could explain why these point mutations do not naturally occur in wild type 
strains. Interestingly, these two residues are far removed from the active site 
predicted from the E. coli LplA-lipoic acid cocrystal structure of Fujiwara et al. 
(Fujiwara et al., 2005). However, we believe the E. coli LplA-lipoic acid complex 
is an experimental artifact because the lipoic acid molecules were 
heterogeneously bound and were poorly resolved (Fujiwara et al., 2005). In one 
case the lipoic acid carboxyl was hydrogen bonded to Ser-72 whereas in another 
case Arg-140 was the hydrogen bond donor (Fujiwara et al., 2005). Since 
enzymes rarely show such plasticity and lipoic acid is a hydrophobic molecule, it 
seemed possible that the observed association of the cofactor with a 
hydrophobic LplA surface in the interdomain cavity was artifactual. Moreover, in 
prior work Reed and coworkers had isolated LplA mutants resistant to inhibition 
by an analogue of lipoic acid in which the sulfur atoms had been replaced with 
selenium (Reed et al., 1994) Since this is a very discrete modification of the LplA 
substrate, the mutant protein would be expected to have an alteration close to 
the pocket that binds the lipoic acid thiolane ring. However, the site of this 
mutation (Gly-76 to serine, (Morris et al., 1995)) was distal from the reported E. 
coli lipoate-binding sites. This dilemma was resolved by two lipoic acid-containing 
structures of an LplA homologue from the Archaeon, Thermoplasma acidophilum 
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(Kim et al., 2005) that can be readily superimposed on the E. coli LplA structure 
except that the T. acidophilum protein lacks the E. coli LplA C-terminal domain. 
In both T. acidophilum structures the lipoate thiolane ring was adjacent to the 
glycine residue that corresponds to E. coli Gly-76, the residue giving resistance 
to the selenium analogue and a plausible reorganization of the molecule to 
prevent binding of the slightly larger analogue was proposed (McManus et al., 
2006). Moreover, addition of lipoic acid to a complex of the T. acidophilum LplA 
with ATP gave lipoyl-AMP which demonstrated that the lipoic acid was bound in 
a physiologically meaningful manner (Kim et al., 2005). Residue 19, the LplA 
residue altered in suppressor strain FH145, is close to the lipoic acid binding 
pocket in the Thermoplasma acidophilum LplA/lipoyl-AMP cocrystal structure, 
although the side chain faces away from the lipoyl moiety. Given the importance 
of the two suppressor mutations we studied (as demonstrated by their reisolation 
by random mutagenesis), it is noteworthy that E. coli LplA residues 19 and 221 
are not conserved in the LplA proteins of other organisms and neither are the 
residue substitutions found in the V19L and S221P mutants. The V19L mutation 
replaces a hydrophobic residue with one having a longer side chain. This could 
increase the affinity of the protein for octanoic acid by creating a more 
hydrophobic environment. The S221P mutation might open up the lipoic 
acid/octanoic acid binding pocket and thereby increase substrate access. Except 
for the F78Y and H79N substitutions, the residue changes of the other mutant 
LplA proteins isolated by random mutagenesis are not readily interpretable. The 
altered residues either lie far away from the active site or seem rather modest 
substitutions. However, a caveat is that although the V19L change is very 
modest in character (one branched chain residue for another), the mutation has 
very marked effects on enzyme activity. Judging from the T. acidophilum crystal 
structures residue F78 is located in the ATP binding pocket whereas H79 is 
located in the lipoic acid binding pocket. Both residues make direct interactions 
with substrate. However, residue 78 is a threonine in the T. acidophilum protein.  
The Regulon Data Base (http://regulondb.ccg.unam.mx/) predicts that lplA is 
cotranscribed with the upstream gene, ytjB. This prediction is consistent with the 
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data of Morris et al. (1995) who showed that insertion of a strong transcription 
terminator into ytjB results in deficiency in lipoic acid utilization in a lipA 
background that is alleviated by trans expression of LplA, but not of YtjB (then 
called Smp) (Morris et al., 1995). This is relevant to two puzzling lplA alleles that 
were isolated in our random mutagenesis of lplA with selection for lipB 
suppression (Table 2.3). Isolates 35R3 and 35R5 have point mutations in the ytjB 
termination codon. In both strains the termination codon was changed from TGA 
to the more stringent TAA stop codon. Read-through of TGA codons has often 
been reported and the nucleotide immediately downstream of the termination 
codon is known to have a major influence on the efficiency of termination (Tate 
and Mannering, 1996). It seems noteworthy that TGAC the sequence found at 
the end of ytjB is the weakest of the four base translational stop signals (Tate 
and Mannering, 1996). The ytjB termination codon is 27 nucleotides upstream of 
the lplA initiation codon and thus any read-through would add the ytjB coding 
sequence plus the nine codons of the intergenic region to the N-terminus of LplA 
with possible deleterious effects on LplA activity. Indeed, if, as annotated, YtjB is 
a membrane protein, the fusion protein could also mislocalize LplA activity. 
Another possibility is that ribosomes transversing the intergenic region might 
interfere with lplA translational initiation, resulting in decreased LplA levels. The 
more stringent TAA codon would more efficiently block translation of the 
intergenic region (Tate and Mannering, 1996) and perhaps raise LplA expression 
to a level sufficient to allow effective utilization of the cytosolic octanoic acid pool.  
It could be argued that decreased read-through would be a minor effect. 
However, it should be noted that the physiological requirement for lipoic acid is 
very low (only hundreds of molecules/cell) and thus slight overproduction of wild 
type LplA (e.g., by vector copy number) is sufficient to allow growth of lipB null 
strains on glucose minimal medium. Moreover, not all of the available lipoyl 
domains need be lipoylated for optimal PDH and OGDH complex activities 
(Guest et al., 1985, Jordan and Cronan, 2002) 
It has long been thought that there are no cytosolic free fatty acids in E. coli 
because fatty acid biosynthesis is tightly coupled to phospholipid biosynthesis. 
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However free fatty acids are detected when phospholipid synthesis is blocked 
(Cronan et al., 1975) and in strains overexpressing a cytosol-entrapped TesA 
thioesterase (Cho and Cronan, 1995). In both cases detection required that the 
strains were defective in β-oxidation. Cho and Cronan (Cho and Cronan, 1995) 
detected traces of octanoic acid. The difficulties in detecting short chain fatty 
acids such as octanoate comes from their partial solubility in water and their 
increased volatility relative to the long chain fatty acids found in membrane lipids. 
In addition, free fatty acids are generally converted to their methyl esters for 
analysis and such short chain methyl esters are even more volatile than the 
parent acids. For these reasons we employed a different strategy. The free fatty 
acids were first converted to their nonvolatile salts then extracted into an organic 
solvent following acidification. We then made the butyl esters which are less 
volatile than the methyl esters (and therefore less likely to be lost), but sufficiently 
volatile to allow analysis by GC-MS.  
The question remains as to the source of this intracellular pool of free fatty acids. 
We constructed strains lacking the TesA and TesB thioesterases in our 
suppressor backgrounds but these strains retained the ability to grow on glucose 
minimal medium (data not shown). However, there are five other thioesterases in 
E. coli of unassigned function which may contribute to the pool. Alternatively, the 
pool may be formed by spontaneous hydrolysis of acyl-ACPs or of intermediates 
bound to the fatty acid elongation enzymes (e.g., the 3-ketoacyl-ACP synthases). 
A final possibility is that the pool is generated by hydrolytic removal of acyl chains 
inappropriately incorporated by an acyltransferase. Evidence for such an editing 
reaction by the phospholipid acyltransferases has been reported (Rock et al., 
1981).  
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Tables  
Table 2.1: Bacterial strains, plasmids and primers used in this work. 
Strain Relevant Characteristics Reference 
CAG18430 mdoB202::Tn10 (Singer et al., 1989) 
DK574 SJ16 carrying plasmids pMS421 
and pMR19 
(Cronan and Thomas, 2009) 
FH6 lipB::Tn1000Km This study 
FH26 lipB::Tn1000Km lplA10 This study 
FH27 lipB::Tn1000Km lplA11 This study 
FH46 FH26 lplA::Tn10tet This study 
FH47 FH27 lplA::Tn10tet This study 
FH57 lipA::Tn1000Km lipB::Tn10Tet 
lplA10 
This study 
FH58 lipA::Tn1000Km lipB::Tn10Tet 
lplA11 
This study 
FH35 FH27 mdoB202::Tn10 This study 
FH66 FH26 mdoB202::Tn10 This study 
FH145 lipB::Cm mdoB202::Tn10 lplA10 This study 
FH146 lipB::Cm mdoB202::Tn10 lplA11 This study 
FH213 MG1655 carrying plasmids pMS421 
and pJH2 
This study 
JK1 rpsL (Morris et al., 1995) 
KER184 rpsL lipB::Tn1000Km (Morris et al., 1995) 
KER310 rpsL lipA::Tn1000Km lipB::Tn10Tet (Morris et al., 1995) 
QC146 lipB lplA (Christensen and Cronan, 
2009) 
TM135 rpsL lplA::Tn10Tet (Morris et al., 1995) 
YFJ239 BL21 carrying plasmid pYFJ84 (Jiang et al., 2006) 
ZX221 rpsL lipB::Cm (Christensen and Cronan, 
2009) 
Plasmids   
pFH1  lplA11 on pQE2 This study 
pFH5 lplA10 on pQE2 This study 
pJH2 Lysis plasmid (Crabtree and Cronan, 
1984) 
pMR19 Encodes acpP (Cronan and Thomas, 2009) 
pMS421 Expresses LacIq (Cronan and Thomas, 2009) 
pGS331  hybrid lipoyl domain on ptac (Ali and Guest, 1990) 
pTJ93 acpS (Cronan and Thomas, 2009) 
pYFJ16 lplA on pQE2 (Jiang and Cronan, 2005) 
pYFJ84 Vibrio harveyi aasS on pET16b (Jiang et al., 2006) 
Primers   
lplAfor TGGCAATCGGTGTAGTGCTG This study 
lplArev GCGCTTGGTTAACGGCGATC This study 
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Table 2.2: Kinetic parameters for wild type, V19L and S221P LplA proteins 
for octanoate. 
 Km  
(µM) 
Vmax  
(nmole/min) 
Kcat  
(mole/min/mole) 
Kcat/Km 
Wildtype 214.3±37.8 2.4 X10-2±0.34X10-2 2.4±0.34 0.011 
V19L 10.4 ±3.0 1.6X10-2 ±0.18X10-2 1.6±0.18 0.058 
S221P 4.0 ±1.6 0.25X10-2 ±0.79X10-4 0.25±0.79X10-2 0.063 
 
 
 
 
Table 2.3: Results of random mutagenesis of lplA and selection for growth 
of a lipB null mutant. US: mutations upstream of the coding sequence; DS: 
mutations downstream of the coding sequence. 
Isolate LplA Mutations 
12R3 E116A, E312K, L328F, US, DS 
12R4 S8T, N63K, F78Y, A110T 
12R7 R58L, H79N 
35R3/ 35R5 F35L, V113I, 4US 
35R4 F15S, T101A, S114I, 3US 
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Figures 
 
Figure 2.1: Lipoic acid metabolism in E. coli.  
A: The LplA lipoate ligase reaction. Lipoate reacts with ATP to form the activated 
intermediate, lipoyl-adenylate (lipoyl-AMP) which remains firmly bound in the 
active site. The lipoyl-adenylate mixed anhydride bond is then attacked by the ε-
amino group of the target lysine residue of the acceptor lipoyl domain to form 
lipoylated protein. LplA also utilizes octanoic acid.  
B: Lipoic acid synthesis in E. coli. LipB transfers an octanoyl moiety from the 
fatty acid biosynthetic intermediate, octanoyl-ACP, to the lipoyl domain of a 
lipoate accepting protein (in this case the E2 subunit of a 2-oxoacid 
dehydrogenase). The octanoylated-domain is the substrate of LipA, an S-
adenosylmethionine radical enzyme that replaces one hydrogen atom on each of 
octanoate carbons 6 and 8 with sulfur atoms. 
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Figure 2.2: PDH (solid bars) and OGDH (open bars) activities of various 
isogenic strains grown on glucose minimal medium supplemented with 
succinate and acetate. The values reported are the averages of three 
measurements. Strain JK1, wild type: strain ZX221, lipB FH145: lipB lplA10 and 
FH146: lipB lplA11. 
 
 
 
 
 
Figure 2.3: Western blot analysis of protein lipoylation. All strains were 
isogenic and produced a hybrid lipoyl domain encoded by plasmid pGS331 (Ali 
and Guest, 1990). Equal amounts of total extract protein were loaded in each 
lane. In panel A the cells were from cultures grown without octanoic acid 
supplementation whereas in panel B the cultures were grown with octanoic acid 
supplementation. Lane 1: lipoyl domain standard; lane 2: strain JK1 (wild type); 
lane 3: strain TM135 (lplA); lane 4: strain ZX221 (lipB); lane 5: strain FH145 
(lipBlplA10); and lane 6: strain FH146 (lipBlplA11). 
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Figure 2.4: Gel shift assay with V19L LplA and octanoyl-ACP as substrate. 
Two preparations of octanoyl-ACP (undialyzed and dialyzed) were tested. Lanes 
3, 5, 7 and 9 were controls for the integrity of the octanoyl-ACP thioester bond in 
both preparations because LipB cannot utilize free octanoic acid. In these four 
lanes the modified domain migrates more rapidly than the unmodified domain. In 
the LipB reactions a holo-ACP band is seen at the top of the gel. In lanes 2 and 4 
V19L LplA catalyzed modification of the domain in presence of an undialyzed 
octanoyl-ACP preparation. However, there was no accumulation of holo-ACP 
indicating that octanoyl-ACP was not the source of octanoate. In lane 6, an 
extensively dialyzed octanoyl-ACP preparation was the substrate and no 
modification of the domain was seen. In lane 8 ATP was added which resulted in 
some modification of the domain which may be due to hydrolysis of octanoyl-
ACP to give free octanoate. The S221P LplA protein gave essentially identical 
results. 
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Figure 2.5: Gas chromatogram of the butyl esters of free fatty acid from cell 
extracts. The internal standard butyl-heptanoate peak represents 50 ng.  The 
mass spectra of the butyl esters of heptanoate, octanoate and decanoate were 
identical to those of authentic standards and the data bases. 
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Chapter 3: An NAD Synthetic Reaction Bypasses the Lipoate 
Requirement for Aerobic Growth of Escherichia coli Strains 
Blocked in Succinate Catabolism4 
 
Introduction 
The enzyme cofactor lipoic acid ((R)-5-(1,2-dithiolan-3-yl)pentanoic acid; 6,8-
dithiooctanoic acid) is essential for the function of two enzyme systems of 
aerobic metabolism in Escherichia coil: pyruvate dehydrogenase (PDH) and 2-
oxoglutarate dehydrogenase (OGDH). A third lipoate-dependent enzyme system, 
the glycine cleavage system (GCV), which functions in the metabolism of glycine 
to a C1 unite and ammonia, is also present in E. coli. However, since GCV 
expression is dependent on the presence of glycine and is not required for 
aerobic growth, it will not be further discussed (Stauffer, 2004, Douce et al., 
2001).  
PDH catalyzes the oxidative decarboxylation of pyruvate, the end product of 
glycolysis, to acetyl-CoA (Fig. 3.1). The acetate moiety of acetyl-CoA is 
condensed with oxaloacetate to form citrate, the first intermediate of the 
tricarboxylic acid (TCA) cycle. Additionally, acetyl-CoA is the building block for 
fatty acids and the amino acid, leucine. PDH is required for aerobic growth of E. 
coli because the other major pyruvate-dissimilating enzyme, pyruvate:formate 
lyase (Pfl), has an oxygen labile active site and is inactive in the presence of air 
(Sawers and Watson, 1998). E. coli contains a third pyruvate-metabolizing 
enzyme, pyruvate oxidase (PoxB). However, PoxB is mainly expressed during 
early stationary phase (Abdel-Hamid et al., 2001, Chang et al., 1994) and is less 
efficient in energy conservation because it produces free acetate, which must be 
activated to acetyl-CoA at the expense of ATP. 
                                            
4
 Results presented in this chapter have been accepted for publication in the Journal Molecular 
Microbiology. 
39 
 
Halfway through the TCA cycle, citrate is broken down to 2-oxoglutarate, which 
undergoes oxidative decarboxylation to succinyl-CoA by the second lipoate-
dependent enzyme system, OGDH (Fig. 3.1). Succinyl-CoA is used in the 
biosynthesis of the amino acids lysine and methionine, and the peptidoglycan 
component, diaminopimelic acid. Succinyl-CoA is also the source of succinate, 
the entry point to respiration (Cronan and Laporte, 2006). OGDH activity is 
dispensable under conditions where the TCA cycle operates as a branched 
pathway, such as during anaerobic growth (Creaghan and Guest, 1972). In such 
instances, fumarate is the source of succinate and hence succinyl-CoA.  
The major pathways that utilize succinyl-CoA (methionine and lysine synthesis) 
do not consume the succinate moiety. Rather succinate is released intact into the 
cytoplasm and can be recycled by succinyl-CoA ligase (Fig. 3.1).  Hence 
succinate is said to function “catalytically” in these biosynthetic pathways. In wild 
type cells however, free succinate is consumed by oxidation to fumarate by 
succinate dehydrogenase (SDH; Fig. 3.1), requiring succinyl-CoA to be 
continuously supplied by OGDH. Thus mutations in SDH greatly lower the 
demand for production of new succinyl-CoA by OGDH. In SHD mutants very 
small amounts of succinate suffice because of succinate recycling by succinyl-
CoA ligase (Fig. 3.1).  
However, the exact cellular requirement for succinate in strains defective in 
succinate catabolism (SDH) has been difficult to determine because disruption of 
OGDH function does not result in a succinate requirement for growth, a finding 
that suggests that E. coli has other pathways of succinate production (Creaghan 
and Guest, 1977).  
PDH and OGDH are very large complexes made up of multiple copies of three 
different subunits named E1, E2 and E3. The E2 subunits each contain at least 
one lipoyl domain (LD), a highly conserved structure of about 80 residues 
(Cronan, 2008, Cronan et al., 2005). Lipoate is attached by an amide bond to a 
specific lysine residue of each of these domains and functions as a “swinging 
arm”, carrying reaction intermediates between the active sites of the three 
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subunits (Perham, 2000). Whereas the E1 and E2 subunits are encoded by 
genes which are distinct for each complex, the lpd gene encodes the E3 subunits 
of both PDH and OGDH.  
In a markedly atypical biosynthetic pathway, lipoate is assembled from the eight-
carbon fatty acid, octanoate, following octanoate attachment to the LDs.  In E. 
coli the assembly proceeds in two steps. First, octanoyltransferase (LipB) 
transfers an octanoyl moiety from the octanoyl-acyl carrier protein (ACP) of fatty 
acid biosynthesis to the specific lysine residues of the LDs (Jordan and Cronan, 
2003, Hassan and Cronan, 2011, Zhao et al., 2005, Zhao et al., 2003). Lipoyl 
synthase (LipA) then catalyzes replacement of single hydrogen atoms at carbons 
6 and 8 with sulfur atoms, by use of radical SAM chemistry (Booker et al., 2007, 
Miller et al., 2000). In an alternative scavenging pathway, exogenous lipoate (or 
octanoate) can be directly attached to the LDs by lipoate protein ligase (LplA). 
LplA uses ATP to activate the acyl chain by forming acyl-AMP, the mixed 
anhydride of which is then attacked by the LD lysine residue (Green et al., 1995, 
Morris et al., 1994, Morris et al., 1995, Zhao et al., 2003).  
Since ∆lipB strains are defective in lipoate synthesis, aerobic growth of these 
strains on glucose minimal media should strictly depend on supplementation with 
either lipoate (or octanoate) or acetate plus succinate. The latter combination of 
supplements, respectively, bypass the PDH- and OGDH-catalyzed steps 
required for TCA cycle function (Herbert and Guest, 1968). (However, see the 
Results section below.) We previously isolated and characterized ∆lipB 
suppressor strains which grew on glucose minimal media lacking any 
supplements (Hermes and Cronan, 2009). In these strains, the mutations 
causing suppression mapped to the lplA gene and resulted in amino acid residue 
changes in the LplA proteins which reduced the enzyme Km values for free 
octanoate. This led us to search for intracellular free octanoate, which was 
detected at a concentration above that of the Km values for the mutant LplA 
proteins. Thus suppression of the ∆lipB defect in these strains was caused by 
activation of PDH and OGDH by the mutant LplA enzymes using cytosolic 
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octanoate (Hermes and Cronan, 2009). This screen also gave rise to a single 
∆lipB suppressor strain (strain FH34) which retained the wild type lplA sequence 
indicating that suppression in this strain was due to a different mechanism. We 
report the deciphering of this distinct and rather intricate mode of suppression. 
Materials and Methods 
Bacterial strains and growth conditions:  
The strains used in this study (Table 3.1) were derivatives of E. coli wild type K-
12 strain MG1655. Strains with the W3110 background were used only as 
marker donors for the construction of strains in the MG1655 background. P1 
transductions and transformations were carried out using conventional methods 
(Ausubel et al., 2007, Miller, 1992). The Dasenko and Wanner method (Datsenko 
and Wanner, 2000) was applied to the construction of several strains. Primers 
used are indicated in table 3.1 and their sequences in table 3.2.  
Strain FH34 was isolated in a previous screen by plating strain FH6 on 
unsupplemented glucose minimal plates (Hermes and Cronan, 2009).  
Strains were maintained on Luria-Bertani agar plates (Miller, 1992). Phenotypic 
analyses were conducted in either liquid culture or on plates using minimal E 
medium (Vogel and Bonner, 1956)  with 0.4% glucose as carbon source. 
Supplements were added at the following concentrations unless otherwise 
specified: acetate, 5 mM; succinate, 5 mM; octanoate, 50 µM; nicotinic acid, 100 
µM; diaminopimelic acid, 100 µg ml-1; lysine 10 µg ml-1; and methionine, 50 µg 
ml-1. Antibiotics were used at the following concentration (in µg ml-1): sodium 
ampicillin, 100; tetracycline HCl, 15; kanamycin sulfate, 50 and chloramphenicol, 
20. The growth temperature was 370C.  
Growth curve experiments were done in a Bioscreen C instrument.  Colonies 
were inoculated into 1 ml glucose minimal medium containing the appropriate 
supplements and grown overnight. The cells were pelleted, washed three times 
with 200 µl minimal medium and resuspended in the same medium to a final 
OD600 of 0.15. Each well contained 290 µl of medium to which 10 µl of cell 
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suspension was added to give a final starting OD600 of 0.005 (about 3 X 10
8 cells 
ml-1). The Bioscreen instrument was set to constant very strong intensity shaking 
to give maximal aeration. The means of three biologically independent growth 
curves are presented. When necessary, a succinate starvation step was 
performed before initiating the growth curves. After the wash and resuspension 
steps described above, cells were subcultured into fresh media lacking succinate 
to an initial OD600 of 0.02 and allowed to grow for 5 to 6 hours.  
Three plasmids were used in this study. pGS133 is a low copy vector carrying 
the sdhCDAB operon with its native promoter (Kita et al., 1989), and pBH146 
contains the sucB gene under control of a tac promoter (Hassan and Cronan, 
2011). Plasmid FH112 was constructed by PCR amplification of the nadB from 
genomic DNA using primers NcoI-nadB and HindIII-nadB (Table 3.2) and cloning 
the PCR product into NcoI/HindIII treated pKK233-2 (Amann and Brosius, 1985), 
thus placing nadB under trc expression. 
PDH and OGDH activity assays:  
The method described in (Hermes and Cronan, 2009) was followed with the 
exception that supplements were added as indicated here, and cell lysis was 
performed using the BugBuster Master Mix (Novagen) per the manufacturer’s 
instructions. The means and standard deviations of three repeat measurements 
are presented. 
Mapping the suppressor mutation of strain FH34:  
The first step was to link the mutation causing lipoate-independent growth in 
strain FH34 (referred to here as the lip+ marker) to a tetracycline resistance 
marker and move it into strain FH160 (∆lipB::FRT::cmR::FRT). P1 phage was 
grown on a pool of about 3000 colonies of strain W1458 containing random Tn10 
insertions (lab collection) and used to transduce strain FH34 to tetracycline 
resistance. About 19,000 colonies were pooled and used to prepare a new P1 
stock which was used to transduce strain FH160 to tetracycline resistance. The 
resulting isolates were screened for retention of chloramphenicol resistance and 
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gain of the lip+ phenotype. In one such isolate, named FH272, tetracycline 
resistance and the lip+ phenotype were 34% linked. FH272 was used for further 
mapping. 
The first step was necessary in order to separate the suppressor mutation from 
the kanamycin resistant element used to disrupt lipB in the original strain and 
thereby enable the use of the mini-Tn5 kanamycin resistant transposon of 
plasmid pRL27 for mapping (Larsen et al., 2002). Strain FH272 was transformed 
with a preparation of pRL27 by electroporation, followed by selection for 
kanamycin resistance. (At this point we had reason to suspect that suppression 
was caused by a recessive mutation.) A P1 phage stock was prepared on a pool 
of the resulting transductants and used to transduce FH160 to kanamycin 
resistance. Isolates were screened for retention of chloramphenicol resistance 
and gain of the lip+ phenotype. One isolate was obtained (FH278) in which 
kanamycin resistance and lip+ were 26.3% linked. Sequencing out from the mini-
Tn5 transposon, followed by a BLAST search revealed that the transposon had 
inserted into the ybfC gene.  
Next using P1 lysates of strains from the Singer (Singer et al., 1989) and Keio 
(Baba et al., 2006) collections, selecting for the antibiotic resistance marker of 
the donor and screening for the lip+ marker and antibiotic resistance marker of 
the recipient (or selecting for both antibiotic resistance markers), the lip+ marker 
was localized to the region between ybgO and mngA. Finally, using the primers 
P1-P24 (Table 3.2), the region between these two genes was sequenced and 
compared to the sequence of the same region in GenBank (accession number 
U00096.2).  
Results 
The ∆lipB strain FH160 contains functional PDH and requires only 
succinate for aerobic growth on glucose minimal media.  
As stated in the Introduction, it is expected that the PDH and OGDH complexes 
of ∆lipB strains would be inactive as a result of an inability to synthesize 
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endogenous lipoate. Thus ∆lipB strains should be incapable of aerobic growth on 
glucose minimal medium without supplementation with both acetate and 
succinate which, respectively, bypass the PDH- and OGDH-dependent steps 
required for TCA cycle function. We will refer to glucose minimal medium 
supplemented with acetate and succinate as “bypass medium”. We reported the 
above growth phenotype and the lack of detectable PDH and OGDH function in 
∆lipB strains grown on bypass medium (Hermes and Cronan, 2009). A somewhat 
conflicting observation was previously reported by our laboratory (Reed and 
Cronan, 1993). The ∆lipB strain used in that study grew on minimal medium 
supplemented only with the products of the OGDH reaction; that is, acetate 
supplementation was not required. Additionally extracts of the Reed and Cronan 
∆lipB strain grown on bypass medium contained about 20% of the wild type PDH 
activity and about 10% of the wild type level of lipoate (Reed and Cronan, 1993).  
We observed that the ∆lipB strains FH6 and FH160 behaved similarly to the 
∆lipB strain of Reed and Cronan (Reed and Cronan, 1993). Strains FH6 and 
FH160 required only succinate for growth on glucose minimal medium (Fig. 3.2A 
and data not shown). This growth phenotype suggested functional PDH was 
present and this was indeed detected in extracts of strain FH160 (Fig. 3.2B) and 
was significantly increased upon supplementation with the LplA substrate and 
lipoate precursor, octanoate. In contrast OGDH activity was only detected when 
exogenous octanoate was provided in the growth medium. Thus the lack of 
detectable OGDH activity explains the requirement of the strain for succinate 
supplementation. We determined that the ∆lipB strain FH160 requires 12 µM 
succinate for half maximal growth in aerobic glucose minimal medium (Fig. 3.2A). 
Acetate-independent growth was not observed for ∆lipB ∆lplA and ∆lipB ∆lipA 
strains (Table 3.4) which indicated that the LplA/LipA pathway was responsible 
for the residual PDH activity of ∆lipB strains (Hermes and Cronan, 2009).  
We have chosen to measure growth in liquid media rather than on solid media to 
avoid the possibility of acetate and/or succinate production by anaerobic 
pathways active in the anoxic cells present in the interior of colonies. Indeed, 
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Creaghen and Guest (1977) encountered this problem in their studies of the 
phenotypes of E. coli lpd strains. 
Lipoate synthesis in the ∆lipB suppressor strain FH34 is required for PDH 
activity, but not OGDH activity.  
Strain FH34 was isolated as a suppressor of the ∆lipB mutation of strain FH6, 
which had acquired the ability to grow on unsupplemented glucose minimal 
medium (Fig. 3.3A). FH34 also grew on glycerol minimal medium although at a 
reduced rate, but did not grow on acetate or succinate as sole carbon sources. 
Since lipoate biosynthesis is dispensable for anaerobic growth (Vanden Boom et 
al., 1991), one possible explanation for the growth phenotype of strain FH34 was 
a cellular switch to anaerobic metabolism. During anaerobic growth acetyl-CoA is 
produced by pyruvate formate lyase (pflB) whereas succinate is produced from 
fumarate by fumarate reductase (frdABCD). Alternatively, acetate can be 
produced aerobically, albeit less efficiently, by pyruvate oxidase (poxB), 
expression of which is under RpoS control (Abdel-Hamid et al., 2001, Chang et 
al., 1994). In order to test if any of these genes played a role in the growth of 
strain FH34, we constructed strains in the FH34 background in which these 
genes were deleted. The resulting strains retained acetate- and succinate-
independent growth on glucose minimal medium (Table 3.4) and thus these 
genes were not involved in the suppression phenotype.  
Having excluded the hypothesis that anaerobic metabolism and/or PoxB provide 
acetate and succinate, the most straightforward explanation for the phenotype of 
strain FH34 was that the strain retained PDH activity and that the mutation giving 
suppression of the ∆lipB mutation somehow resulted in activation of OGDH. In 
∆lipB strains the LplA/LipA pathway is the only source of endogenous lipoate 
needed to activate the PDH and OGDH complexes. LplA attaches the free fatty 
acid octanoate to the complexes and LipA converts the octanoyl modification to 
the lipoyl cofactor to give the active dehydrogenases (Zhao et al., 2003). In order 
to test if OGDH was being activated in strain FH34 via the known LplA/LipA 
route, ∆lplA and ∆lipA gene deletions were individually constructed in strain 
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FH34. The resulting two strains acquired an acetate requirement for growth on 
glucose minimal medium similar to the ∆lipB parental strain (Table 3.4). The 
∆lplA and ∆lipA deletion derivatives of strain FH34, however, remained 
succinate-independent. This indicated that either OGDH was activated by a 
mechanism independent of lipoate or that OGDH activity was not essential for 
growth of strain FH34 due to the presence of other succinate production 
pathways. 
We had previously reported that ∆lipB strains are suppressed by point mutations 
in the lplA gene which decrease the enzyme Km for octanoate thus enabling 
these enzymes to utilize the cytoplasmic pool to modify PDH and OGDH 
(Hermes and Cronan, 2009). We therefore sequenced the lplA gene of strain 
FH34 and found it to have the wild type sequence. The ∆lipB deletion phenotype 
is known to be suppressed by overexpression of lplA (Morris et al., 1995). 
Therefore, Southern blot analyses were performed using probes specific to the 
lipB and lplA genes in order to eliminate the possibility that gene duplication 
caused the suppression (prior work from this laboratory had demonstrated 
duplication of the lipB locus (Jordan and Cronan, 2002)). The genomic DNA blot 
patterns of strains FH6 and FH34 were identical (data not shown). Moreover, the 
nucleotide sequence upstream of the lplA gene in FH34 had the wild type 
sequence, thus eliminating the possibility of a promoter mutation that altered lplA 
expression. 
The ∆lipB suppressor strain FH34 lacks detectable OGDH activity.  
As stated above a possible explanation for the succinate-independent growth of 
strain FH34 was the presence of active OGDH. Thus crude extracts of strain 
FH34 grown on bypass medium were assayed for PDH and OGDH activities. As 
was the case with the ∆lipB parent (Fig. 3.2B), FH34 extracts contained 
functional PDH, but no detectable OGDH activity (Fig. 3.3B). In a further test a 
∆lpd derivative of strain FH34 was constructed. Since lpd encodes a subunit 
common to both PDH and OGDH, strains defective in Lpd activity require both 
acetate and succinate supplementation for aerobic growth on glucose (Langley 
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and Guest, 1978). However the ∆lpd derivative of strain FH34 required acetate, 
but not succinate for growth (Table 3.4). Taken together these two observations 
indicated that detectable levels of OGDH activity were not essential for growth of 
strain FH34 and that there must be other sources of cellular succinate.  
The mutation causing suppression of the ∆lipB gene deletion of strain 
FH34 maps to the sdhB gene and inactivates succinate dehydrogenase.  
Using two and three factor transductional crosses, the mutation causing 
suppression of the ∆lipB gene deletion in strain FH34 was localized to the 18 Kbp 
region between the genes ybgO and mngA (Table 3.3). The diverse phenotypes 
and polarity of the metabolic gene cluster gltA-sdhCDAB-sucAB-sucCD 
complicated analysis of results of transductional crosses within this region. We 
therefore sequenced the entire region and found a single nucleotide change in 
the sdhB gene, which encodes the iron-sulfur subunit of the succinate 
dehydrogenase (SDH) complex. The mutation changed sdhB codon 51 from a 
glutamine codon to a termination codon (CAG  TAG). Sequencing showed this 
mutation was not present in the MG1655 wild type and FH6 ∆lipB strains.  
To confirm that the termination codon caused the growth phenotype of strain 
FH34, a ∆lipB ∆sdhB strain was constructed in the MG1655 (wild type) 
background. The resulting strain FH420 grew on unsupplemented glucose 
minimal medium thus recapitulating strain FH34 (Table 3.4). Moreover, when a 
low-copy number plasmid encoding the complete sdhCDAB operon was 
introduced into a ∆lipB ∆sdhB strain, the resulting derivative was unable to grow 
without succinate supplementation (Table 3.4).  
Strains containing ∆lipB ∆sdhA and ∆lipB ∆sucA deletions were also able to grow 
on unsupplemented glucose minimal medium (Table 3.4). The sdhA gene is 
located upstream of sdhB and encodes the flavoprotein subunit of the SDH 
complex. Hence, any deletion that inactivates SDH results in suppression of the 
∆lipB mutation. As seen above in the ∆lipB ∆sdhB strain, succinate-independent 
growth of the ∆lipB ∆sucA strain was lost upon introduction of a plasmid 
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encoding the sdhCDAB operon (Table 3.4). This suggested that the ∆sucA 
mutation caused disruption of sdhB expression, possibly by destabilizing the 
polycistronic mRNA (Cunningham and Guest, 1998). Since sucA encodes a 
subunit of OGDH, the phenotype of the ∆lipB ∆sucA strain further supports the 
observation that OGDH function is not essential for succinate production in ∆lipB 
strains that lack SDH activity, such as strain FH34 (∆lipB ∆sdhB). A ∆lipB ∆sucB 
strain however failed to grow on unsupplemented glucose minimal medium 
(Table 3.4) indicating that the ∆sucB deletion does not exert the effect on the 
expression of the sdhCDAB operon seen for the ∆sucA deletion. We note that 
deletion strains of the Keio collection (Baba et al., 2006) were used to construct 
the ∆lipB ∆sucA and ∆lipB ∆sucB strains. These gene deletions are in frame only 
upon excision of the antibiotic resistance marker, and the markerless ∆lipB 
∆sucA and ∆lipB ∆sucB versions of our strains retained the phenotypes 
described here.   
Succinate is produced and must be recycled to succinyl-CoA in ∆lipB 
∆sdhB strains.  
The biosynthetic pathways that utilize succinyl-CoA do not consume the 
succinate moiety. In methionine biosynthesis, the succinate moiety of succinyl-
CoA is used to form an ester bond with homoserine (the reaction catalyzed by 
MetA) which is subsequently attacked by the thiol group of cysteine in the MetB 
reaction with the release of free succinate. Theoretically any homoserine ester 
will fulfill this role. Indeed metA deletion strains are methionine auxotrophs but 
grow when provided with exogenous acetyl-homoserine in place of methionine 
(Flavin and Slaughter, 1967, Nagai and Flavin, 1967). Moreover, many plant 
MetB enzymes prefer acetyl-homoserine over succinyl-homoserine (Hacham et 
al., 2003). A similar argument can be made for the role of succinyl-CoA in the 
biosynthetic pathway of lysine and diaminopimelic acid. Ultimately the free 
succinate generated in the cytoplasm by these pathways has two fates. It is 
either oxidized to fumarate by SDH or is reattached to CoA by succinyl-CoA 
ligase (succinyl-CoA synthetase) encoded by the sucCD genes (Fig. 3.1). We 
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hypothesized that if a small amount of succinate was produced in the ∆lipB 
∆sdhB strains then sucCD would be essential for scavenging succinate via its 
ligation to CoA. On the other hand if the role of succinyl-CoA was being fulfilled 
by another acyl-CoA, such as acetyl-CoA, then sucCD could be dispensable. In 
order to test this hypothesis we constructed a deletion of the sucCD genes in the 
∆lipB ∆sdhB strain. The resulting ∆lipB ∆sdhB ∆sucCD strain required lysine and 
methionine for growth (Table 3.4). This indicated that succinate was indeed 
produced and must be recycled to succinyl-CoA in the ∆lipB ∆sdhB strains. The 
surprising acetate requirement for growth of the ∆lipB ∆sdhB ∆sucCD strain is 
currently under study.    
The pathways of succinate synthesis in ∆lipB ∆sdhB strains.  
The question then became the source(s) of the succinate. Three straightforward 
sources of succinate in strains lacking functional SDH and OGDH complexes had 
previously been suggested by Creaghan and Guest (Creaghan and Guest, 
1977).  These were isocitrate lyase (AceA), fumarate reductase (FrdABCD) and 
oxidation of succinate semialdehyde (which was proposed to be produced by 
activity of the E1 subunit of OGDH (Frank et al., 2008)). To test these 
hypotheses we constructed deletions of the aceA, frdA and sucAB genes 
individually and in combination in the ∆lipB ∆sdhB strain and screened for the 
ability of these strains to grow without succinate supplementation. The ∆lipB 
∆sdhB strain that contained deletions of aceA, frdA and sucAB retained 
succinate-independent growth on glucose minimal (Table 3.4) indicating that yet 
another source of succinate remained.  
Given the elimination of the straightforward sources we considered the activity of 
aspartate oxidase (NadB), the first enzyme in the de novo pathway of 
nicotinamide adenine dinucleotide (NAD) synthesis. NadB catalyzes the 
oxidation of aspartate to iminosuccinate and can use either oxygen or fumarate 
as oxidant (Korshunov and Imlay, 2010). When fumarate is used it is reduced to 
succinate. The NAD synthetic pathway differs from typical coenzyme biosynthetic 
pathways in that it has a high flux; the levels of NAD and its derivatives are about 
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1 mM (Bochner and Ames, 1982, Wimpenny and Firth, 1972).  We introduced a 
∆nadB deletion into the ∆lipB ∆sdhB ∆frdA ∆aceA ∆sucAB strain. The resulting 
strain required succinate for growth on glucose minimal medium containing 
nicotinic acid (Table 3.4). The succinate requirement was alleviated upon 
introduction of a vector expressing nadB (Table 3.4). By construction of various 
combinations of the four gene deletions in the ∆lipB ∆sdhB strain, we determined 
that only three of the four deletions were required to produce the succinate-
dependent growth phenotype; ∆aceA, ∆nadB, and ∆sucAB (Fig. 3.4). The 
succinate requirement for growth of strain FH698 (∆lipB ∆sdhB ∆aceA ∆nadB 
∆sucAB) was expected to be very low.  Indeed, supplementation of glucose 
minimal medium with only 250 nM succinate gave half maximal growth (Fig. 3.4).  
The contribution of OGDH was surprising given that the activity of this enzyme in 
extracts of the ∆lipB ∆sdhB strain was consistently below the detection level 
(~0.005 µmole substrate mg-1 protein hr-1 (Reed and Cronan, 1993)), and that 
deletion of lplA, lipA or lpd in the ∆lipB ∆sdhB background did not block succinate 
independent growth (see above). However, it is now clear that the lack of effect 
of the aforementioned genetic manipulations in the ∆lipB ∆sdhB background on 
succinate production is due to the presence of the two other sources of 
succinate, namely NadB and AceA. In order to further understand the exact role 
of OGDH, individual deletions of genes encoding its constituent subunits were 
constructed in the ∆lipB ∆sdhB ∆aceA ∆nadB background. An in frame sucB 
gene deletion in the ∆lipB ∆sdhB ∆aceA ∆nadB strain resulted in a succinate 
requirement (Table 3.4) suggesting that full OGDH activity was responsible for 
the succinate independent growth of the ∆lipB ∆sdhB ∆aceA ∆nadB strain, and 
not just the succinate- or succinate semialdehyde-producing activity of the E1 
subunit (sucA). Interestingly, introduction of an lpd deletion into the ∆lipB ∆sdhB 
∆aceA ∆nadB strain did not result in a succinate requirement. This result is in line 
with studies that show that dihydrolipoamide can be oxidized under certain 
conditions by glutaredoxins with electrons passing to glutathione (Feeney et al., 
2011). This also explains why we were unable to detect OGDH activity in the 
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∆lipB ∆sdhB strain since our assay measures reduction of the NAD+ analogue, 3-
acetylpyridine adenine dinucleotide, by Lpd. 
Discussion 
When ∆lipB strains were first isolated “leaky” growth phenotypes on aerobic 
medium supplemented with nutrients that bypassed the OGDH-catalyzed 
reaction, i.e. succinate, or lysine plus methionine, were reported (Morris et al., 
1995, Reed and Cronan, 1993, Vise and Lascelles, 1967). This acetate-
independent growth phenotype was suggestive of the ability of ∆lipB strains to 
produce either lipoate for activation of PDH, or acetate/acetyl-CoA by some other 
means. The later characterization of LplA (Green et al., 1995) and the detection 
of a cytoplasmic pool of free octanoate (the precursor of lipoate and a LplA 
substrate) (Hermes and Cronan, 2009) elucidated the source of lipoate and thus 
acetyl-CoA in ∆lipB strains. In contrast ∆lipB ∆lplA strains do not exhibit acetate-
independent growth. The reported concentration of cytoplasmic octanoate (28.2 
µM) is well below the Km for octanoate of the wild type LplA enzyme (214.3 µM) 
(Hermes and Cronan, 2009). However, since the origin of cytoplasmic octanoate 
could be spontaneous hydrolysis of the thioester bond of the acyl-ACP of fatty 
acid biosynthesis, it is conceivable that strain background and/or growth 
conditions may affect the availability of free octanoate for lipoate synthesis by the 
LplA/LipA pathway and thus the potential for acetate-independent growth of ∆lipB 
strains. We observed both acetate plus succinate-dependent and succinate only-
dependent growth phenotypes in ∆lipB strains constructed in two strain 
backgrounds; MG1655 and W3110 (data not shown). Despite the presence of 
cytoplasmic octanoate and LplA, the levels of OGDH are undetectable in ∆lipB 
strains, although PDH is active. A plausible explanation for this phenomenon is 
that E. coli PDH has three LDs whereas OGDH has only a single LD.  Only one 
of the three PDH LDs must be modified for essentially full enzymatic activity 
(Stepp et al., 1981, Ambrose-Griffin et al., 1980, Angelides and Hammes, 1978, 
Berman et al., 1981, Danson et al., 1978, Hackert et al., 1983).  Thus, PDH 
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would seem to have a competitive advantage over OGDH when octanoate is 
limiting. 
We have now characterized three ∆lipB suppressor strains able to grow on 
unsupplemented glucose minimal medium. In two of these strains suppression 
was caused by single point mutations in the lplA gene which gave LplA enzymes 
having significantly reduced Km values for octanoate (Hermes and Cronan, 
2009). These mutant LplA enzymes were thus able to utilize cytoplasmic 
octanoate to activate PDH and OGDH. In the third ∆lipB suppressor strain, 
described herein, suppression resulted from inactivation of the SDH respiratory 
enzyme complex (encoded by the sdhCDAB operon). SDH catalyzes the 
oxidation of succinate to fumarate, freeing two protons for participation in ATP 
synthesis via ATP synthase. Since each molecule of glucose is broken down to 
two molecules of succinate, and ATP synthase requires 12 protons to produce 
one molecule of ATP, strains defective in SDH activity are expected to produce 
one-third less energy than wild type. This is reflected in the growth rate of the 
∆lipB ∆sdhB strain which is only two thirds that of the wild type strain (0.429 hr-1 
and 0.637 hr-1, respectively; Fig. 3.3A). However, despite its moderate 
importance in energy production, succinate plays a key biosynthetic role. 
Initially it seemed perplexing that blockage of succinate consumption would 
enable a ∆lipB strain to grow on aerobic glucose minimal medium since it had 
been generally assumed that ∆lipB strains lack the ability to produce succinate.  
However, Creaghan and Guest (Creaghan and Guest, 1977) isolated sdh null 
mutants in their search for suppressors of the succinate requirement of a ∆lpd 
strain and this was taken to indicate that E. coli has other modes of succinate 
synthesis (Cronan and Laporte, 2006). In the ∆lipB ∆sdhB strain we found that 
succinate/succinyl-CoA were provided by the activities of isocitrate lyase (AceA), 
aspartate oxidase (NadB) and OGDH (Fig. 3.5). Any one of the three enzymes 
provided sufficient succinate for growth. NadB was the unexpected member of 
this troika. NadB is a very unusual enzyme in that it can use either an organic 
acid, fumarate, or an inorganic molecule, oxygen, as an electron acceptor. Under 
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physiological aerobic growth conditions NadB utilizes oxygen as an electron 
acceptor because the cellular fumarate concentration is low (Korshunov and 
Imlay, 2010). However, fumarate is the preferred substrate and its presence can 
block oxygen utilization under aerobic conditions (Korshunov and Imlay, 2010). 
The intracellular concentration of fumarate in aerobically grown E. coli does not 
exceed 10 μM (Korshunov and Imlay, 2010).  However, even such 
concentrations would be sufficient to provide the low concentrations of succinate 
required for growth of the ∆lipB ∆sdhB strains which show half maximal growth at 
250 nM succinate (Fig. 3.4). In contrast, ∆lipB strains fail to grow under these 
conditions because these strains require 12 μM succinate for half maximum 
growth, about a 50-fold greater concentration than that required for the ∆lipB 
∆sdhB strains (Fig. 3.2A).  
The contribution to succinate production by OGDH was surprising because 
OGDH activity in these strains was consistently below the level of detection (Fig. 
3.3B) and deletion of genes that are essential to both PDH and OGDH function 
(lipA, lplA or lpd) in the ∆lipB ∆sdhB background affected acetate, but not 
succinate production (Table 3.4). On the other hand, the remaining, albeit 
undetectable, OGDH activity may explain why ∆lipB strains (and the ∆lipB ∆sdhB 
∆sucCD strain of this study) require lysine plus methionine but not 
diaminopimelic acid for growth. Interestingly, despite reports suggesting low-level 
expression of fumarate reductase during aerobic growth (Cecchini et al., 1995, 
Jones and Gunsalus, 1985, Tseng et al., 1996, Tseng et al., 1994), deletion of 
frdA was not required to engender succinate auxotrophy in the ∆lipB ∆sdhB 
∆aceA ∆nadB ∆sucAB strain. Moreover, in this strain background introduction of 
deletions of either lplA or lpd in place of the sucAB deletion gave strains that did 
not require succinate but did require acetate (Table 3.4).  Therefore 2-
oxoglutarate dehydrogenase was able to function without the E3 subunit or the 
LplA lipoate ligase activity. These results indicate that under conditions where 
only traces of succinate are required, normally insignificant noncanonical 
pathways become significant.  As mentioned above a glutaredoxin-glutathione 
couple can replace lpd (Feeney et al., 2011) and disruption of lplA severely 
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decreased but did not completely eliminate attachment of lipoate and octanoate 
to SucB (Morris et al., 1994) indicating the presence of another low activity 
mechanism to modify SucB. The requirement for SucB modification was 
demonstrated by the finding that expression of a SucB protein lacking the 
lipoylated lysine residue (K44) failed to restore succinate independence to the 
∆lipB ∆sdhB ∆aceA ∆nadB ∆sucB strain (Table 3.4).  Note that the acetate 
requirement engendered by replacement of the ∆sucAB or ∆sucB deletions with 
∆lpd or ∆lplA deletions is readily explained by the fact that, unlike succinyl-CoA, 
the acetyl-CoA produced by pyruvate dehydrogenase is a major cellular building 
block. 
The structure and regulation of the sdhCDAB-sucAB-sucCD operon(s) has been 
the subject of numerous studies (Conway et al., 2014, Cunningham and Guest, 
1998, Masse and Gottesman, 2002, Spencer and Guest, 1985). If sucB is 
cotranscribed with sdhB, we would expect reduced SucB expression in ∆sdhB 
strains. If so, the resulting decreased cellular LD concentration could result in a 
sparing effect on the cytoplasmic octanoate pool, thus freeing it for use in 
activation of PDH. However, we observed that in the ∆lipB background, deletions 
of the ∆sdhB and ∆sucA genes give a phenotype that differs from that of the 
∆sucB deletion, suggesting that these genes may not be strictly cotranscribed. 
Both the ∆sucA and the ∆sucB deletions disrupt OGDH function, but only the 
former spares the succinate pool probably by reducing SDH expression. The 
∆sucB deletion is not polar on the downstream sucCD genes, because the ∆lipB 
∆sucB strain can utilize exogenous succinate, a characteristic that would require 
functional succinyl-CoA ligase (SucCD). Additionally a plasmid carrying the sucB 
gene alleviates the succinate requirement of the ∆lipB ∆sdhB ∆aceA ∆nadB 
∆sucB strain (Table 3.4). 
Finally it should be noted that the ability to decipher the interrelationships of 
central metabolism is the direct product of advances in E. coli genetics that allow 
facile construction of null mutations in the genes of interest (Datsenko and 
Wanner, 2000, Court et al., 2002).  Although the seminal work of Guest and 
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coworkers (Creaghan and Guest, 1972, Creaghan and Guest, 1977, Guest and 
Creaghan, 1973, Langley and Guest, 1978) opened many doors in this area, 
interpretation of results obtained using the point mutants then available would 
have been compromised by possible residual activities of the encoded proteins.  
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Tables  
Table 3.1: Description of strains used in this study. 
Name Relevant genotype Construction or reference 
FH6 lipB::Tn1000 km
R (Hermes and Cronan, 2009) 
FH34 lipB::Tn1000 km
R sdhB (amber) 
lip+ 
Suppressor of the ∆lipB 
mutation of strain FH6 
FH160 ∆lipB::FRT::cmR::FRT MG1655 X p(ZX221) 
FH419 ∆lipB::FRT::cmR::FRT 
∆sdhB::FRT::kmR::FRT 
FH160Xp(JW714) 
FH420 ∆lipB::FRT ∆sdhB::FRT pCP20 transformation of 
FH419 (Datsenko and 
Wanner, 2000) 
FH497 ∆lipB::FRT ∆sdhB::FRT 
∆sucAB::FRT::cmR::FRT 
Datsenko and Wanner in 
FH420 using primers 
sucAKOfor and sucBKOrev  
FH663 ∆lipB::FRT ∆sdhB::FRT 
∆sucCD::FRT::cmR::FRT 
Datsenko and Wanner in 
FH420 using primers 
sucCDKOfor and 
sucDCKOrev 
FH686 ∆lipB::FRT ∆sdhB::FRT 
∆nadB::FRT::kmR::FRT 
FH420 X p(JW2558) 
FH691 ∆lipB::FRT ∆sdhB::FRT 
∆nadB::FRT 
pCP20 transformation of 
FH686 (Datsenko and 
Wanner, 2000) 
FH695 ∆lipB::FRT ∆sdhB::FRT 
∆nadB::FRT 
∆aceA::FRT::kmR::FRT 
FH691 X p(JW3975) 
FH698 ∆lipB::FRT ∆sdhB::FRT 
∆nadB::FRT 
∆aceA::FRT::kmR::FRT 
∆sucAB::FRT::cmR::FRT 
FH695 X p(FH497) 
FH705 ∆lipB::FRT ∆sdhB::FRT 
∆nadB::FRT 
∆aceA::FRT::kmR::FRT 
∆sucB::FRT::cmR::FRT 
Datsenko and Wanner in 
FH695 using primers 
sucBKOfor and sucBKOrev 
FH706 ∆lipB::FRT ∆sdhB::FRT 
∆nadB::FRT 
∆aceA::FRT::kmR::FRT 
∆sucA::FRT::cmR::FRT 
Datsenko and Wanner in 
FH695 using primers 
sucAKOfor and sucAKOrev 
QC146 ∆lipB::FRT ∆lplA::FRT (Christensen and Cronan, 
2009) 
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Table 3.1 Continued.  
The following strains were used for mapping and/or as donors to construct 
deletions of various genes in the above strains. 
Name Relevant genotype Construction or reference 
CAG12077  pagP::Tn10 (Nichols et al., 1998, Singer 
et al., 1989) 
CAG12147 nadA::Tn10 (Nichols et al., 1998, Singer 
et al., 1989) 
CAG12149  dsbG::Tn10 (Nichols et al., 1998, Singer 
et al., 1989) 
CAG18433  asnB::Tn10 (Nichols et al., 1998, Singer 
et al., 1989) 
CAG18493  Contains a Tn10 insertion in the 
intergenic region between genes 
ybhL and ybhM 
(Nichols et al., 1998, Singer 
et al., 1989) 
FH272 ∆lipB::FRT::cmR::FRT lip+ linked to 
Tn10 of unknown location 
FH160 x P1 (pool of FH34 
with random Tn10 
insertions), followed by 
screening for lip+ 
FH278 ∆lipB::FRT::cmR::FRT lip+ linked to 
Tn5 
(Tn5 located in ybfC) 
FH160 x P1(pool of FH272 
with random Tn5 
insertions), followed by 
screening for lip+ 
FH302 CAG12077 lipB::Tn1000 km
R CAG12077 Xp(FH6) 
FH303 CAG12149 lipB::Tn1000 km
R CAG12149 Xp(FH6) 
FH304 CAG18433 lipB::Tn1000 km
R CAG18433 Xp(FH6) 
FH305 CAG18493 lipB::Tn1000 km
R CAG18493 Xp(FH6) 
FH308 lipB::Tn1000 km
R lip+ nadA::Tn10 FH34 X p(CAG12147) 
FH316 ∆lipB::FRT::cmR::FRT lip+ 
nadA::Tn10 
FH160Xp(FH308) 
JW112 ∆lpd::FRT::kmR::FRT (Baba et al., 2006) 
JW697 ∆ybgA::FRT::kmR::FRT (Baba et al., 2006) 
JW709 ∆ybgD::FRT::kmR::FRT (Baba et al., 2006) 
JW713 ∆sdhA::FRT::kmR::FRT (Baba et al., 2006) 
JW715 ∆sucA::FRT::kmR::FRT (Baba et al., 2006) 
JW716 ∆sucB::FRT::kmR::FRT (Baba et al., 2006) 
JW717 ∆sucC::FRT::kmR::FRT (Baba et al., 2006) 
JW721 ∆mngA::FRT::kmR::FRT (Baba et al., 2006) 
JW732 ∆ybgF::FRT::kmR::FRT (Baba et al., 2006) 
JW755 ∆ybhC::FRT::kmR::FRT (Baba et al., 2006) 
JW855 ∆poxB::FRT::kmR::FRT (Baba et al., 2006) 
JW886 ∆pflB::FRT::kmR::FRT (Baba et al., 2006) 
JW2558 ∆nadB::FRT::kmR::FRT (Baba et al., 2006) 
JW3975 ∆aceA::FRT::kmR::FRT (Baba et al., 2006) 
JW4115 ∆frdA::FRT::kmR::FRT (Baba et al., 2006) 
JW5098 ∆ybgO::FRT::kmR::FRT (Baba et al., 2006) 
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Table 3.1 Continued.  
Name Relevant genotype Construction or reference 
JW5100 ∆tolB::FRT::kmR::FRT (Baba et al., 2006) 
KER310 W3110 str
R lipA::Tn1000 Km 
lipB::Tn10 
(Reed and Cronan, 1993) 
TM134 W3110 str
R lplA::Tn10 (Morris et al., 1995) 
ZX221 W3110 str
R ∆lipB::FRT::cm::FRT (Christensen and Cronan, 
2009) 
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Table 3.2: Sequences of primers used in this study. 
Name Sequence 
sucAKOfor AGTATCCACGGCGAAGTAAGCATAAAAAAGATGCTTAAGG
GATCACGATGTGTAGGCTGGAGCTGCTTCG 
sucAKOrev ATCTACGCTACTCATTGTGTATCCTTTATTTATTCGACGTT
CAGCGCGTCATATGAATATCCTCCTTAG 
sucBKOfor GATCTGGTTAATGACGCGCTGAACGTCGAATAAATAAAGG
ATACACAATGTAGGCTGGAGCTGCTTCG 
sucBKOrev GGTCTACAGTGCAGGTGAAACTTAAACTACTACACGTCCA
GCAGCAGACGATATGAATATCCTCCTTAG 
sucCDKOfor GGTCTACGGTTTAAAAGATAACGATTACTGAAGGATGGAC
AGAACACATGGTGTAGGCTGGAGCTGCTTC 
sucCDrevfor CGGCGAGGGCTATTTCTTATTACAGATATTTATTTCAGAAC
AGTTTTCAGCATATGAATATCCTCCTTAG 
NocI-nadB GCGCCATGGATACTCTCCCTGAACATTC 
HindIII-nadB GCGAAGCTTATCTGTTTATGTAATGATTG 
P1 AGTGAACAGCAGAGATACGG 
P2 GGCAATCTTCATACCGTCAC 
P3 GTGGAGGTAGAGGCGTTCTG 
P4 TCGGGAAACCGCGGTGCAGC 
P5 GTTATCGTGACCTGGATCAC 
P6 AAGCTTCCGCGATTATGGGC 
P7 TTGCACTGGTGGTTTACGTG 
P8 CGCTTTATCAGCAGAACCTG 
P9 CCTGGGTAAAGAAGTTCTCG 
P10 GGCTTGAGCAGTTGAAAGTG 
P11 AAGGTGTGTGCGGTTCCGAC 
P12 TCGGCCATATCAAGTCGATG 
P13 TGACACCAATGTGAAGCAGG 
P14 ACCGTGGTCGTCTGAACGTG 
P15 AACGCGGACGATCCGGAAGC 
P16 GTGAGAAACTGTTCGACTGG 
P17 ACCACATGCTGCGTCGTCAG 
P18 TGGTTAATGACGCGCTGAAC 
P19 GAAAGAGTCTGCTCCGGAAG 
P20 ATCAAAGATCGTCCGATGGC 
P21 GGTTATGCCTGTACTACTCC 
P22 ACCTGGCGTTGATCGAAATC 
P23 GCGAAGAAACTGGCTGACAG 
P24 GTATCCAGCCTGGTCACATT 
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Table 3.3: Transductional crosses used to map the amber mutation in 
strain FH34. 
Cross 
Antibiotic resistance 
marker location Linkage Notes 
FH34Xp(CAG12149) dsbG 0%  
FH34Xp(CAG12077) pagP 1%  
FH34Xp(CAG18433) asnB 4.3%  
FH34Xp(CAG18493) Intergenic region 
between ybhL and ybhM 
4.3%  
FH34Xp(CAG12147) nadA 69.7%  
FH316Xp(JW755) ybhC 6.9% This cross 
indicated that the 
tetR marker of 
FH316 (in nadA) 
was between the 
lip+ marker and 
the KmR marker in 
ybhC 
FH316Xp(JW697) ybgA 58% lip+ to the right of 
ybgA 
FH316Xp(JW5098) ybgO 84.9% lip+ to the right of 
ybgO 
FH316Xp(JW709) ybgD 88.9%  
FH316Xp(JW713) sdhA 0%  
FH316Xp(JW715) sucA 0%  
FH316Xp(JW716) sucB 0%  
FH316Xp(JW717) sucC 100%  
FH316Xp(JW721) mngA 83.3% lip+ to the left of 
mngA 
FH316Xp(JW5100) tolB 81.3%  
FH316Xp(JW732) ybgF 72.2% lip+ to the left of 
ybgF 
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Table 3.4: Acetate and succinate requirements for aerobic growth on 
glucose minimal medium of MG1655 strains with various gene deletions. 
Genetic Manipulation 
Supplement Requirement 
Acetate Succinate 
∆lipB background (Strains FH6 and FH160) 
None No Yes 
∆lplA Yes Yes 
∆lipA Yes Yes 
∆sdhB No No 
∆sdhA No No 
∆sucA No No 
∆sucB No Yes 
∆sdhB/ p(sdhCDAB) No Yes 
∆sucA/ p(sdhCDAB) No Yes 
∆lipB ∆sdhB background (Strains FH34 and FH420) 
∆poxB No No 
∆pflB No No 
∆poxB pflB No No 
∆frdA No No 
∆lplA Yes No 
∆lipA Yes No 
∆lpd Yes No 
∆sucCD Yes Lysine and 
methionine  
(but not DAP) 
∆aceA No No 
∆sucAB No No 
∆frdA ∆aceA ∆sucAB No No 
∆frdA ∆aceA ∆sucAB ∆nadB No Yes 
∆frdA ∆aceA ∆sucAB ∆nadB/ 
p(nadB) 
No No 
∆nadB No No 
∆frdA ∆nadB No No 
∆sucAB ∆nadB No No 
∆frdA ∆aceA ∆nadB No No 
∆frdA ∆sucAB ∆nadB No No 
∆aceA ∆nadB ∆sucAB No Yes 
∆aceA ∆nadB ∆sucA No Yes 
∆aceA ∆nadB ∆sucB No Yes 
∆aceA ∆nadB ∆sucAB / p(sucB) No Yes 
∆aceA ∆nadB ∆sucB / p(sucB) No No 
∆aceA ∆nadB ∆lpd Yes No 
∆aceA ∆nadB ∆lplA Yes No 
∆aceA ∆nadB ∆sucB / p(sucBK44R) No Yes 
 
62 
 
Figures 
 
Figure 3.1: Schematic of central metabolism showing the decarboxylation 
reactions catalyzed by the lipoate-dependent enzyme complexes, pyruvate 
dehydrogenase (PDH) and 2-oxoglutarate dehydrogenase (OGDH). The 
dotted arrows point to the biosynthetic pathways that utilize a given intermediate. 
Also shown is succinate recycling by the succinate:CoA ligase (also called 
succinyl-CoA synthetase and succinate thiokinase). Abbreviations: PDH, 
pyruvate dehydrogenase; OGDH, 2-oxoglutarate dehydrogenase; SucCD, 
succinate:CoA ligase; SDH, succinate dehydrogenase; and DAP, diaminopimelic 
acid.  
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Figure 3.2: The ∆lipB strain FH160 contains active PDH consistent with 
growth on glucose minimal medium without acetate supplementation.  
A: Growth characteristics of strain FH160 on glucose minimal medium. 
Supplementation with a final concentration of 12 µM succinate allowed growth at 
half the maximal rate.  
B: PDH and OGDH activities of extracts of strain FH160. Strain FH160 was 
grown in glucose minimal medium containing the supplements indicated. 
Although PDH activity was consistently detected, OGDH activity was detected 
only when octanoate was provided in the growth media to support lipoate 
synthesis. Error bars indicate the standard deviations of three repeat 
measurements. ND: not detected (below ~0.005 µmole substrate mg-1 protein hr-
1 (Reed and Cronan, 1993)).  
 
64 
 
 
 
Figure 3.3: Strain FH34 grows in the absence of succinate supplementation 
despite having no detectable OGDH activity.   
A: Growth characteristics on unsupplemented glucose minimal medium of the 
wild type (MG1655), the ∆lipB strain (FH160) and the ∆lipB suppressor strain, 
FH34.  
B: PDH and OGDH activities of extracts of strain FH34 and the wild type strain. 
The strains were grown on glucose minimal medium supplemented with acetate 
and succinate. Error bars indicate the standard deviations of three repeat 
measurements. ND: not detected (below ~0.005 µmole substrate mg-1 protein hr-
1 (Reed and Cronan, 1993)). 
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Figure 3.4: The ∆lipB ∆sdhB ∆aceA ∆nadB ∆sucAB strain (FH698) requires 
succinate for growth on glucose minimal medium supplemented with 
nicotinic acid. Nicotinic acid (100 µM) was added to allow synthesis of NAD.  
The strain was grown in minimal medium containing various concentrations of 
succinate as shown. Succinate at a final concentration of 250 nM gave half the 
maximal growth rate.  
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Figure 3.5: Pathways of succinate production in the ∆lipB ∆sdhB strain. 
Residual OGDH activity produces succinyl-CoA, whereas the glyoxylate shunt 
enzyme isocitrate lyase (AceA) cleaves isocitrate to succinate plus glyoxylate 
which is ultimately converted to malate. Malate is also produced from 
oxaloacetate in the branched mode of the TCA cycle (shown here). Malate is 
dehydrated to fumarate which is utilized by aspartate oxidase (NadB) to oxidize 
aspartate concomitant with reduction of fumarate to succinate. Free succinate 
from the AceA and NadB reactions is scavenged and converted to its CoA 
thioester by succinate:CoA ligase (SucCD). 
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Chapter 4: The Role of the Saccharomyces cerevisiae Lipoate 
Protein Ligase Homologue, Lip3, in Lipoic Acid Synthesis5 
 
Introduction 
Since the initial demonstration, purification and synthesis of lipoic acid in the 
early 1940s (Reed, 2001), much has been learned about the synthesis of this 
essential respiratory cofactor in prokaryotes (Cronan et al., 2005, Cronan, 2008). 
In Escherichia coli, lipoate is assembled on the lipoyl domains (LDs) of the 
lipoate-dependent enzyme systems from the eight carbon fatty acid, octanoate, 
in two steps. First, an octanoyltransferase (LipB) transfers an octanoyl moiety 
from the acyl carrier protein (ACP) of fatty acid synthesis to the LDs (Jordan and 
Cronan, 2003). A thioester-bound acyl-enzyme intermediate is formed in the 
process (Zhao et al., 2005). Then lipoyl synthase (LipA) catalyzes replacement of 
single hydrogen atoms at carbons 6 and 8 with sulfur atoms using radical SAM 
chemistry (Booker et al., 2007). Alternatively, exogenous lipoate or octanoate 
can be directly attached to LDs by lipoate protein ligase (LplA) via an acyl-AMP 
intermediate.  
Although the LipA sulfur insertion reaction is conserved in all characterized 
lipoate synthesis pathways, there are three well-characterized variations to the E. 
coli pathway in the other reactions. In the lipoate auxotrophic archeon 
Thermoplasma acidophilum, the lipoate protein ligase is composed of two 
separately encoded subunits LplA and LplB that together catalyze formation of 
the acyl-AMP intermediate (Posner et al., 2009, Christensen and Cronan, 2009). 
LplB was found to be dispensable for the second half reaction, namely ligation of 
the acyl moiety to the acceptor lysine on the LDs (Christensen and Cronan, 
2009). The Gram-positive bacterium Bacillus subtilis lacks a LipB homologue, but 
encodes three LplA homologues, although only LplJ has the ligase function of E. 
                                            
5 Results presented in this chapter are published in the journal Yeast (2013) 
30(10):415-27.  
 
68 
 
coli LplA (Martin et al., 2011). One of the two remaining homologues (LipM) is an 
octanoyltransferase that specifically transfers octanoate from ACP to a small 
protein, GcvH (Christensen and Cronan, 2010), whereas LipL, the third 
homologue, is an amidotransferase that transfers the octanoyl moiety from GcvH 
to the LDs of pyruvate dehydrogenase (PDH), the branched chain oxoacid 
dehydrogenase, and oxoglutarate dehydrogenase (OGDH) (Christensen et al., 
2011b, Martin et al., 2011). LipL is also present in Listeria monocytogenes along 
with two other LplA homologues that are ligases. LplA1 specifically modifies 
GcvH whereas the LD specificity of LplA2 is undetermined (Christensen et al., 
2011a). The lipoate scavenged by L. monocytogenes LplAs might come directly 
from the host environment or might be released from host lipoylated-peptides by 
the action of the lipoamidase(s) encoded by this bacterium. 
The diversity in prokaryotic lipoate attachment mechanisms, summarized in Fig. 
1.2, is surprising given the simple structure of the coenzyme. The situation in 
eukaryotes is not well understood and may contribute further enzymatic diversity. 
Early studies of the bovine LplA-homologue (LipT; for lipoyltransferase) 
demonstrated that the enzyme was unable to form the acyl-AMP intermediate 
(Fujiwara et al., 1994). However LipT was able to transfer the acyl chain from 
exogenously provided acyl-AMP to LDs in vitro giving rise to the proposal that 
mammalian lipoate attachment requires a “lipoate-activating enzyme”. 
Accordingly, Fujiwara et al. (2001) purified an enzyme from bovine liver that 
synthesized lipoyl-GMP in vitro which in turn could be utilized by LipT to modify 
LDs (Fujiwara et al., 2001). However this putative lipoate-activating enzyme is 
one of many poorly characterized medium chain fatty acyl-Coenzyme A (CoA) 
ligases that have extremely broad substrate specificities (Kasuya et al., 2006, 
Vessey et al., 2000), and thus the physiological relevance of its in vitro lipoyl-
GMP forming activity is unclear.   
In the yeast, Saccharomyces cerevisiae, there are at least three lipoate-
dependent enzyme systems; PDH, OGDH and the glycine cleavage system 
(GCV). PDH catalyzes the oxidative decarboxylation of pyruvate, the endpoint of 
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glycolysis, to acetyl-CoA and thereby links cytosolic glycolysis and mitochondrial 
respiration. The acetate moiety of acetyl-CoA is condensed with oxaloacetate to 
form citrate, the first intermediate of the tricarboxylic acid (TCA) cycle. 
Mitochondrial acetyl-CoA is also the building block for mitochondrial fatty acid 
(FA) biosynthesis which produces octanoyl-ACP, the precursor of lipoate 
(Hiltunen et al., 2010). OGDH catalyzes the oxidative decarboxylation of the TCA 
cycle intermediate, oxoglutarate, to succinyl-CoA, a precursor of several amino 
acids, and the source of succinate which is the entry point to the respiratory 
chain. GCV is involved in cleavage of glycine to ammonia and C1 units and is 
essential for utilization of glycine as a sole source of nitrogen. All constituents of 
these enzyme systems, as well as those of mitochondrial fatty acid biosynthesis, 
are encoded by nuclear genes and have mitochondrial targeting sequences. 
Their functions are necessary for mitochondrial maintenance and respiratory 
growth (Contamine and Picard, 2000).  
Studies by Schonauer et al. (2009) showed that Lip2, Lip5, Lip3 (the LipB, LipA 
and LplA homologues respectively) as well as Gcv3 (the GcvH homologue) are 
all required for endogenous lipoate synthesis and attachment (Schonauer et al., 
2009). Respiratory growth of a lip2 strain, which contains a wild type copy of the 
lip3 gene, is not supported by exogenous lipoate supplementation (Chen, 1997, 
Marvin et al., 2001), suggesting that S. cerevisiae lacks a lipoate scavenging 
pathway. On the other hand, early studies by Sulo and Martin (Sulo and Martin, 
1993) showed that even though lipoate did not support the respiratory growth of 
lip5 strains, the cells contained a substantial level of protein-bound lipoate when 
grown on lipoate-supplemented media, suggesting the presence of a scavenging 
mechanism in S. cerevisiae.  
We sought to further investigate the role of Lip3 in lipoate synthesis in S. 
cerevisiae. We show that Lip3 has octanoyl-CoA: protein transferase activity and 
present a model for lipoate synthesis in S. cerevisiae.  
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Materials and Methods 
General molecular biology techniques:  
Genomic DNAs were extracted using the Promega Wizard genomic DNA 
purification kit. Plasmids were prepared using either the Qiagen minispin or midi 
kits. PCR was conducted using either Taq (New England Biolabs) or Pfu 
(Invitrogen) polymerase, and appropriately designed primers from IDT (Table 
4.1). Restriction enzymes and ligases were from New England Biolabs. DNA 
sequencing was conducted by the Core Sequencing Facility of the Carver 
Biotechnology Center of the University of Illinois, Urbana Champaign.  
Yeast suspensions for PCR were prepared by suspending a colony in 30 µl of 
0.2% SDS and boiling at 96o for 5 min, then cooling on ice. The suspension was 
then cleared at 3000xg for 1 min, and 10 µl of supernatant was diluted with 67 µl 
of 10 mM Tris-HCl (pH 8.0) containing 1 mM EDTA. 
Strains and plasmids:  
All E. coli strains, yeast strains and plasmids used in this study, as well as their 
relevant genotypes are listed in Table 4.1.  
Plasmid pFH21 was made by digesting PCR-amplified lip3 with BspHI and 
HindIII and ligating the product to NcoI and HindIII digested pBAD24. The lip3 
gene used was a synthetic gene composed of codons optimized for expression in 
E. coli. Plasmid pFH23 was constructed by moving the ClaI-HindIII fragment 
containing lip3 and the arabinose promoter from pFH21 into pACYC177. Site-
directed mutagenesis of the lip3 gene in plasmid pFH23 was conducted using 
pfuUltra HF from Invitrogen and appropriately designed primer sets per the 
manufacturer’s recommendations. Vector pFH88 was made by PCR amplification 
of the fadK gene from pRK33 using primers fadK-for and fadK-rev. The PCR 
product was digested with NcoI and HindIII and ligated to pBAD322C treated with 
the same restriction enzymes.  
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To construct plasmid pFH72 the last 360 codons of the lip3 gene were PCR 
amplified from a S. cerevisiae cell suspension using primers pPICNTlip3-for 
(which included codons for 6X His tag) and pPIClip3-rev. The PCR product was 
digested with BamHI and EagI and ligated into pPIC3.5K treated with the same 
restriction enzymes. Plasmid pFH38 was constructed by ligation independent 
cloning (Eschenfeldt et al., 2009) of a synthetic gcv3  gene altered to have E. coli 
optimized codons into pMCSG7.  
Vector pFH46 is a pUC-type vector which carries a synthetic 126 bp fragment 
encoding the first 42 amino acids of the predicted mitochondrial targeting 
sequence of S. cerevisiae Coq3. The sequence was flanked by a BamHI cut site 
upstream and KpnI and PstI sites immediately downstream. The lplA and lipB 
genes were PCR amplified from E. coli total genomic DNA using primers mtlplA-
for and mtlplA-rev and mtlipB-for and mtlipB-rev, respectively. B. subtilis lipL was 
amplified from plasmid pQC32 using primers mtlipL-for and mtlipL-rev. The 
amplified genes were ligated into the KpnI and PstI sites of pFH46 and their 
sequences verified. The result of this step was to introduce a mitochondrial 
targeting sequence at the N-termini of LplA, LipB and LipL. The resulting 
plasmids were then digested with BamHI and PstI and the appropriate DNA 
fragments were ligated to the E. coli-S. cerevisiae shuttle vector pCM188 treated 
with the same restriction enzymes.  
pFH18 contains the lip2 gene synthesized using codons optimized for expression 
in E. coli.  The gene was inserted between the NcoI and HindIII sites of pBAD24 
under control of an arabinose promoter. pFH87 contains an N-terminal 6X His-
tagged lip2 gene in pQE80K (Qiagen) under control of a tac promoter. It was 
constructed by PCR amplification of lip2 from pFH18, digestion of the PCR 
product with BamHI (site included in the primer) and HindIII and ligating the 
product into pQE80K cut with the same enzymes. pFH87 was transformed into 
the E. coli ∆lipB ∆lplA strain QC146 to give strain FH590. 
E. coli strains were transformed by heat shock treatment (Seidman et al., 1997). 
To construct a fadD gene replacement in strain FH306, a P1 phage stock was 
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grown on strain RMK75 and the lysate was used to transduce FH306 to 
chloramphenicol resistance following the method of Miller (1992) (Miller, 1992). 
The resulting strain, FH307 failed to grow on oleate as sole carbon source.  
S. cerevisiae strains were transformed using the lithium acetate/single-stranded 
carrier DNA/ polyethylene glycol method of Gietz and Woods (2002) (Gietz and 
Woods, 2002). Transformants were selected on glucose synthetic complete 
uracil dropout medium (see below). Strain FH553 was made by linearizing 
pFH72 with SalI and transforming the linear plasmid into Pichia pastoris strain 
GS115 by electroporation as described by the supplier. Transformants having 
chromosomal integration of the plasmid were selected on glucose synthetic 
complete histidine dropout medium.  
Growth conditions:  
Yeast strains were generally grown at 30o on rich media consisting of yeast 
peptone (YP) containing 1% yeast extract and 2% peptone with either 2% 
glucose, 3% glycerol or 3% ethanol as carbon sources. Selection for 
transformants was done on glucose synthetic complete media missing either 
histidine or urea (Treco, 1993). Methanol (1%) was used to induce protein 
expression in P. pastoris strain FH553. 
E. coli strains were grown at 37o on Luria-Bertani (LB) (Miller, 1992) or glucose 
minimal E media (GMM) (Vogel and Bonner, 1956). Supplements were added to 
the following concentrations: acetate 5 mM, succinate 5 mM, lipoate 7.5 ng ml-1, 
octanoate 50 µM, arabinose 0.2%, and glucose 0.4%. Antibiotics were used at 
the following concentrations (in µg ml-1): sodium ampicillin, 100; spectinomycin 
sulfate, 50; kanamycin sulfate, 50; and chloramphenicol, 20. 
Growth curves:  
Strains were inoculated in 5 ml of minimal E supplemented with arabinose, 
acetate, succinate and appropriate antibiotics and grown two nights at 37o. The 
cells were collected and washed three times with minimal E and diluted to initial 
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OD600 of about 0.01 in 300 µl of growth medium. Growth was followed at 37o on 
a Bioscreen C automated growth curve analysis system set to continuous very 
strong intensity shaking for aeration. The means and standard deviations of 3 
replicates are presented.  
Assays of PDH and OGDH activities:  
The procedure described in Hermes and Cronan (2009) was followed with a few 
differences. The cultures were in 50 ml LB supplemented with arabinose, acetate 
and succinate and either lipoate, octanoate, both, or neither as indicated. Cell 
pellets were lysed using BugBuster Master Mix from Novagen per the 
manufacturer’s protocol. The means and standard deviations of 3 repeat 
experiments are presented.  p-values were calculated using Student’s T-test, 
using a two-tailed distribution of probability for two independent samples 
assuming equal variance. Significance was assigned for conditions who’s p-
values were smaller than 0.05.   
Detection of in vivo lipoylation by western blotting:  
About 150 µg of total protein was fractionated on 12% SDS gels and then blotted 
onto a polyvinylidene difluoride membrane using a standard protocol (Gallagher, 
2010). Lipoylated domain was detected using rabbit anti-lipoyl protein primary 
antibody from Calbiochem and goat anti-rabbit antibody from Roche.  
Protein expression and purification:  
In our hands Lip3 consistently formed inclusion bodies when over expressed in 
E. coli regardless of the strain background and the numerous expression 
conditions attempted. Fusions to maltose binding protein (MBP) were soluble, but 
inactive, and Lip3 aggregated upon cleavage of the solubility tag. Purification 
under denaturing conditions followed by refolding produced inactive protein. We 
therefore resorted to expressing and purifying Lip3 from the yeast P. pastoris. 
Strain FH553 was cultured in YP glycerol overnight at 30o. The cells were 
collected and resuspended to OD600 of 0.5 in 400 ml YP methanol in a two-liter 
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flask and protein production was allowed to proceed overnight. The cells were 
collected, freeze-thawed and resuspended in breaking buffer (50 mM sodium 
phosphate (pH 7.4), 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 5% 
glycerol). Zymolase was added and the suspension was incubated at 30o for an 
hour. The extract was cleared by centrifugation. Hexahistidine tagged Lip3 was 
partially purified using Ni-NTA from Qiagen following the manufacturer’s 
recommendations, and verified using western blotting with anti-his antibody. 
Protein concentrations were measured at 280 nm using the extension coefficient 
55810 M-1cm-1  predicted by the program ProtPram (Gasteiger E., 2005). We 
obtained about 5 µg of protein from 400 ml of culture.    
To express hexahistidine-tagged apo Gcv3, strain FH437 was inoculated in LB 
supplemented with glucose, acetate, succinate, spectinomycin and ampicillin. At 
OD600 of 0.8, protein production was induced overnight with arabinose. Gcv3 
was purified under denaturing conditions with 8 M urea using Ni-NTA 
chromatography. The protein was refolded by gradually removing the urea by 
dialysis. Protein concentration was measured at 280 nm using the extension 
coefficient 26930 M-1cm-1 (ProtPram) (Gasteiger E., 2005). Expression and 
purification of the E. coli LD was conducted as described previously (Hermes and 
Cronan, 2009). 
Holo ACP was expressed and purified, and octanoyl-ACP was prepared as 
described in Hermes and Cronan 2009 (Hermes and Cronan, 2009).  Partially 
purified His-tagged Lip2 was obtained by growing FH590 in 200 ml LB 
supplemented with glucose, acetate, succinate and kanamycin to OD600 of 0.7. 
Protein production was induced for 3 h with 1 mM IPTG. The cells were collected 
and lysed with BugBuster (Novagen). The extract was cleared by centrifugation 
at 5000xg. Lip2 was found mainly in the insoluble fraction. Soluble Lip2 was 
obtained from the supernatant using a column of Ni-NTA (Qiagen) following the 
manufacturer’s recommendations. The presence of His-tagged Lip2 in the 
extracts was verified by western blot using anti-His tag antibodies. 
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Synthesis of octanoyl-Gcv3:   
A 300 µl  reaction contained apo-Gcv3, 10 mM sodium phosphate ( pH7.0), 
0.3mM dithiotheritol, 5 mM MgCl2, 5 mM ATP, 3 mM octanoate (30% 
radiolabeled and C1) and 5 µM LplA. The reaction was incubated overnight at 
37oC. To remove unreacted ATP, 25U of glucokinase (Sigma) and 50 mM 
glucose were added and the reaction was incubated at 30oC for 2 hours followed 
by dialysis in a 3.5K cutoff dialysis bag against 50 mM tris (pH 9.0) containing 10 
mM EDTA and 10% glycerol overnight at room temperature.   
Gel shift activity assays:  
To assay Lip3 activity a 20 µl reaction mixture contained 10 mM sodium 
phosphate buffer (pH 7), 0.3 mM dithiothreitol, about 650 nM Lip3, and either 6 
µM apo Gcv3 or 15 µM apo LD. To test for ligase activity 5 mM MgCl2, 5 mM 
ATP and 1 mM octanoate were added to the reaction. Alternatively 100 µM 
octanoyl-CoA (from Sigma) was added. The reaction was run for 12 hours at 37o, 
after which 15 µl was loaded in a 20% native polyacrylamide gel and separated 
by electrophoresis. To assay Lip2 activity the reactions were set up as described 
above except Lip2 extract was used instead of Lip3 and octanoyl-ACP or 
octanoyl-Gcv3 instead of octanoyl-CoA as indicated.  
Results 
Expression of wild type Lip3 permits growth of an E. coli ∆lipB ∆lplA strain 
on octanoate, but not lipoate supplemented media.  
E. coli strain QC146 is deleted for the lipB and lplA genes which renders it 
defective in both synthesis and scavenge of lipoate. Growth of strain QC146 on 
GMM is strictly dependent on supplementation with acetate and succinate which, 
respectively, bypass the PDH- and OGDH-catalyzed steps required for TCA 
cycle function (Herbert and Guest, 1968). We tested the ability of Lip3 to support 
the growth of strain QC146 either on unsupplemented GMM (i.e. to complement 
the lipB defect), or on GMM supplemented with either lipoate or octanoate (i.e. to 
complement the lplA defect). Strain QC146 containing pFH23, a plasmid that 
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expresses Lip3, failed to grow on either unsupplemented or lipoate 
supplemented GMM but grew on octanoate supplemented GMM (Fig. 4.1A). The 
strain also grew on GMM containing a mixture of lipoate and octanoate (data not 
shown) which indicated that lipoate neither supported nor inhibited growth of 
strain QC146 harboring pFH23. 
Members of the lipoate protein ligase (Lpl) family have a signature catalytic lysine 
that is essential for activity. From the sequence alignment of Lip3 with several 
other Lpl family homologues(Schonauer et al., 2009), K249 was a good 
candidate for the Lip3 catalytic site lysine residue. Replacing K249 with arginine 
had deleterious effects on the ability of Lip3 to complement growth of QC146 
(Fig. 4.1B), whereas replacing K249 with alanine completely eliminated activity 
(Fig. 4.1B).  
The E. coli ∆lipB ∆lplA strain expressing wild type Lip3 contained active 
and lipoylated PDH and OGDH complexes. 
To confirm that growth of strain QC146 containing the Lip3 expression plasmid 
pFH23 on octanoate supplemented media was due to activation of PDH and 
OGDH, the activities of the complexes were assayed in extracts of this strain. 
The strain was grown in LB medium containing acetate, succinate, arabinose (to 
induce Lip3 expression) supplemented with either lipoate, octanoate or left 
unsupplemented. Strain QC146 containing the empty vector grew on these 
media due to the presence of acetate and succinate (see above).  As expected 
the extracts of the vector containing strain had no detectable activity of either 
PDH or OGDH even when both lipoate and octanoate had been added to the 
cultures (Fig. 4.2A). On the other hand, extracts of strain QC146 containing the 
Lip3 expression plasmid grown without lipoate or octanoate, or with lipoate only 
had traces of PDH and OGDH activities (Fig. 4.2A). The trace activities were 
probably due to trace amounts of octanoate in LB medium which can be utilized 
by Lip3 to activate PDH and OGDH.  Addition of octanoate to the cultures of 
strain QC146 containing pFH23 resulted in significantly higher PDH and OGDH 
activities (Fig. 4.2A). 
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To further confirm PDH and OGDH activation in strain QC146 carrying pFH23, 
cell extracts were assayed for lipoylated PDH and OGDH by western blotting 
using a commercial anti-lipoyl LD antibody. A faint band corresponding to SucB 
(the LD-containing subunit of OGDH) but no band for AceF (the LD-containing 
subunit of PDH) was observed in the extracts from unsupplemented and lipoate 
supplemented cultures (Fig. 4.2B, lanes 1 and 2). The SucB band was much 
more prominent in the extract from the octanoate-supplemented culture and an 
AceF band was also present in this extract (Fig. 4.2B, lane 3). We did not expect 
to detect lipoyl-GcvH (the LD of GCV) in this experiment because in E. coli GCV 
is expressed only in the presence of glycine. 
Complementation of the E. coli ∆lipB ∆lplA strain by expression of Lip3 
requires a host-encoded acyl-CoA synthetase. 
The finding that Lip3 selectively utilized octanoate, but not lipoate, in vivo was 
surprising. What was more puzzling was the requirement for octanoate 
supplementation because we had earlier shown that a pool of intracellular free 
octanoate is present in E. coli (Hermes and Cronan, 2009). This pool is sufficient 
for activation of PDH and OGDH either when LplA was expressed from a strong 
promoter or when a mutant enzyme having a lower Km for octanoate was 
present. We therefore reasoned that the actual substrate for Lip3 may not be free 
octanoate per se but the much rarer species, octanoyl-CoA.  We argued against 
octanoyl-ACP as the substrate since this is a standard intermediate of fatty acid 
(and lipoate) synthesis and is thus constitutively present.  If octanoyl-CoA was 
the Lip3 substrate, then a fatty acid-CoA synthetase would be required to convert 
octanoate to octanoyl-CoA.  Hence, growth of the E. coli ∆lipB ∆lplA strain 
carrying the pFH23 Lip3 expression plasmid on octanoate-supplemented GMM 
would depend on the presence of the fadD fatty acid acyl-CoA synthetase of 
aerobic β-oxidation. To test this premise, we deleted fadD and found that the 
resulting strain (strain FH307) was unable to grow on octanoate-supplemented 
GMM (Fig. 4.3A).  Growth of the E. coli ∆lipB ∆lplA strain carrying the Lip3 
plasmid was slow and it seemed likely that this was due to the fact that octanoate 
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is a poor substrate for FadD.  The acyl-CoA synthetase of the anaerobic β-
oxidation pathway FadK has preference for short chain fatty acid substrates 
(Morgan-Kiss and Cronan, 2004). However fadK is only expressed during 
anaerobiosis (Morgan-Kiss and Cronan, 2004). Hence we placed the fadK gene 
downstream of an arabinose promoter and this plasmid was introduced into 
strain QC146 carrying the Lip3 expression plasmid pFH23. The resulting strain 
grew much better on octanoate-supplemented GMM than strain QC146 carrying 
only pFH23 (Fig. 4.3B), thus providing further support for the hypothesis that the 
Lip3 substrate is octanoyl-CoA (or derived from it) rather than free octanoate.  
Lip3 formed octanoyl-LD and octanoyl-Gcv3 in vitro using octanoyl-CoA.  
Lip3 activity in vitro was tested using an electromobility shift assay. Attachment of 
octanoate to the lysine residue of the LD or Gcv3 proteins results in loss of a 
positive charge which gives more rapid migration of the modified protein in native 
electrophoresis gels relative to the unmodified protein. Lip3 was unable to modify 
either LD or Gcv3 when provided with free octanoate, ATP and MgCl2 (Fig. 4.4A 
and data not shown). When octanoyl-CoA was used as acyl donor, Lip3-
catalyzed modification of both LD and Gcv3 was seen (Fig. 4.4A, lanes 1 and 5). 
In contrast to the implications of its in vivo activity, Lip3 also catalyzed 
modification of Gcv3 and LD in vitro with octanoyl-ACP as substrate (Fig. 4.4B 
and 4.5C). No amidotransfer activity was detected for Lip3 in vitro (Fig. 4.4C). 
The extreme insolubility of Lip3 (see MATERIALS AND METHODS) precluded 
further characterization of Lip3 in vitro.  
Lip3 functions downstream of Lip2 in S. cerevisiae.  
As stated earlier lipoate synthesis in S. cerevisiae is required for mitochondrial 
maintenance and respiration. When presented with glucose, S. cerevisiae 
preferentially grows fermentatively even in the presence of oxygen. Fermentative 
growth does not require mitochondria and therefore to test mitochondrial function 
(an indicator of lipoate synthesis) S. cerevisiae must be grown on a 
nonfermentable carbon source such as ethanol. We tested growth of S. 
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cerevisae strains carrying deletions of the lip2, lip3 or gcv3 genes after 
transformation with either an empty vector or a plasmid encoding a 
mitochondrially targeted gene (E. coli lipB, E. coli lplA, or B. subtilis lipL) on rich 
ethanol media.  
The wild type parent, strain BY4741, grew well on rich medium containing 
ethanol in place of glucose (Fig. 4.5) whereas the lip2, lip3 and gcv3 mutant 
strains transformed with the empty vector failed to grow, even when the medium 
was supplemented with octanoate (Fig. 4.5, panel A). Expression of 
mitochondrially targeted E. coli LplA allowed growth of all three mutant strains 
(Fig. 4.5, panel B) indicating that the mutant strains expressed PDH and OGDH 
albeit in their inactive (apo) forms.  Moreover, these data indicate that Gcv3 per 
se is not required for respiration but is required for downstream lipoylation of 
PDH and OGDH.  
Mitochondrially targeted B. subtilis LipL failed to complement the lip2 mutant 
strain but complemented the lip3 mutant strain (Fig. 4.5, panel D). This suggests 
that Lip2 is the primary source of octanoyl-Gcv3, the LipL substrate. E. coli LipB 
produces octanoyl-Gcv3 as indicated by its ability to complement a lip2 strain 
(Fig. 4.5, panel C). However, the inability of LipB to complement the gcv3 strain 
indicates that E. coli LipB cannot efficiently modify S. cerevisiae PDH and 
OGDH. Finally, the inability of LipB to complement the lip3 strain indicates that 
lip3 acts downstream of the octanoyl-Gcv3 formed by either Lip2 or LipB.  
Interestingly, the lip2 strain expressing LipL exhibited slight growth on ethanol 
when octanoate was provided (Fig. 4.5, panel D). This suggests that under these 
conditions, Lip3 (or another as yet unknown enzyme) produces some octanoyl-
Gcv3 which is presented to LipL for modification of PDH and OGDH. The gcv3 
strain expressing LipB also grew slightly on octanoate-supplemented ethanol 
media. This suggests that in the absence of competition with Gcv3 and in the 
presence of excess octanoate Lip3 can modify PDH and OGDH, albeit poorly. 
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Discussion 
Several studies of transgenic mice and clinical observations of human disease 
cases have underscored the essential role of lipoate synthesis in health (Mayr et 
al., 2011, Smith et al., 2012, Yi and Maeda, 2005). Lipoate is an essential 
cofactor for the respiratory enzyme systems, PDH and OGDH. S. cerevisiae 
mutants defective in lipoate synthesis are thus unable to grow on nonfermentable 
carbon sources such as ethanol. These strains form characteristically small 
colonies, called petites, when grown on glucose, because the colonies stop 
growing upon exhaustion of glucose. In contrast colonies of wild type S. 
cerevisiae continue to grow by utilization of the ethanol produced by glucose 
fermentation (Tzagoloff and Dieckmann, 1990). Petite mutants frequently exhibit 
complete loss or extensive deletions of mitochondrial DNA (Contamine and 
Picard, 2000).   
There remain several gaps in our understanding of lipoate synthesis in S. 
cerevisiae. Sulo and Martin (Sulo and Martin, 1993) isolated and characterized 
Lip5, the gene encoding the S. cerevisiae LipA homologue. Interestingly, they 
showed that even though lip5 strains form petite colonies, the cells contained a 
substantial level of protein-bound lipoate when grown on lipoate-supplemented 
media. This observation suggests the presence of a scavenging mechanism in S. 
cerevisiae similar to that of E. coli LplA, B. subtilis LplJ or the T. acidophilum 
LplA/B complex. Why then are lip5 strains respiratory deficient? It is possible that 
the lipoate scavenge pathway modifies only one of the two respiratory enzyme 
systems, while the endogenous lipoate synthesis pathway targets both systems. 
The lipoate scavenging enzyme of S. cerevisiae has yet to be identified since this 
study shows that Lip3, the only known Lpl homologue to date in the yeast, is not 
involved in lipoate scavenge.       
A complete set of type II fatty acid biosynthesis genes, including a gene encoding 
ACP, has been characterized in S. cerevisiae mitochondria (Hiltunen et al., 
2010). Mitochondrial fatty acid biosynthesis produces octanoyl-ACP, the 
substrate for the S. cerevisiae LipB homologue, Lip2. The lip2 genes of both S. 
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cerevisiae and Kluyveromyces lactis have been cloned and disrupted. Although 
the Lip2 proteins of the two yeast species have almost identical amino acid 
sequences, the S. cerevisiae lip2 mutant strain was respiratory deficient whereas 
the K. lactis lip2 strain was not (Chen, 1997, Marvin et al., 2001). Thus the 
differences in the effects of lip2 deletion could reflect diversity in lipoate synthesis 
and/or utilization between the two organisms. We cloned S. cerevisiae lip2 and 
showed that it complements an E. coli ∆lipB ∆lplA mutant strain on 
unsupplemented GMM (Fig. 4.6A). Crude E. coli extracts containing Lip2 had 
octanoyltransferase activity and lacked ligase activity (Fig. 4.6B). It was 
necessary to confirm that Lip2 is indeed an octanoyltransferase because 
octanoyltransferases, amidotransferases and lipoate ligases are difficult to 
distinguish from one another by examination of their amino acid sequences. 
Members of the three groups share minimal amino acid sequence identity yet 
have similar structural folds (Ma et al., 2006, Reche, 2000, Christensen et al., 
2011b). A case in point is LipM which has the sequence of a lipoate ligase but is 
an octanoyltransferase rather than a ligase (Christensen and Cronan, 2010). 
Whereas octanoyltransferases lack an accessory domain, ligases may contain 
the accessory domain at either the C-terminus of the same protein such as the 
case with E. coli LplA (Fujiwara et al., 2010, Fujiwara et al., 2005), or at the N-
terminus, such as the case for Streptomyces coelicolor LplA (Christensen and 
Cronan, 2009), or the accessory domain may be encoded by a completely 
separate gene, such as the T. acidophilum LplB (McManus et al., 2006, Posner 
et al., 2009, Christensen and Cronan, 2009).  
A third and unexpected protein involved in S. cerevisiae lipoate synthesis is 
Gcv3. Gcv3 is a lipoylated protein that is a subunit of the GCV complex of single 
carbon metabolism together with Gcv1, Gcv2 and Lpd1. Work by Schonauer et 
al. (Schonauer et al., 2009) suggests that lipoylation of Gcv3 is required for 
lipoylation of PDH and OGDH. They showed that in a gcv3 strain there is no 
detectable lipoyl-PDH or OGDH. This was true of S. cerevisiae strains containing 
a complete deletion of gcv3 and of strains encoding a mutant Gcv3 that lacked 
the lysine residue modified by lipoate attachment. Deletion of the other GCV 
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subunits had no effect on lipoylation of Gcv3, PDH or OGDH (Schonauer et al., 
2009). The requirement of this apparent “checkpoint” in lipoate synthesis is 
unclear. Perhaps S. cerevisiae uses lipoyl-Gcv3 as a sensor for nutritional 
standing before proceeding with activation of respiratory enzymes. Furthermore 
the operation of this putative checkpoint is unclear. Schonauer and coworkers  
showed that in a lip2 strain there is no detectable lipoylation of either Gcv3 or the 
PDH and OGDH, whereas in a lip3 strain Gcv3 becomes lipoylated (Schonauer 
et al., 2009). One possible explanation for this is that Lip2 specifically modifies 
Gcv3, whereas Lip3 modifies PDH and OGDH once Gcv3 lipoylation is complete. 
In an in vitro assay we noticed that when provided with a mixture of Gcv3 and 
LD, Lip3 modifies only Gcv3 (data not shown). This suggests that Gcv3 has 
priority for modification in S. cerevisiae whether catalyzed by either Lip2 or Lip3. 
Active GCV might be needed at times when active PDH and OGDH are not. 
Indeed, when wild type S. cerevisiae was grown on glucose the sole lipoylated 
protein detected was Gcv3 (Fig. 4.7). In contrast the same strain grown under 
respiratory conditions (on glycerol in place of glucose) contained lipoylated Gcv3, 
PDH and OGDH (Fig. 4.7).  
Note that we were able to bypass the lipoyl-Gcv3 checkpoint to some extent in a 
gcv3 strain by expression of mitochondially-tagged versions of either E. coli LplA 
or E. coli LipB in the presence of excess free octanoate (Fig. 4.5). The lipoyl-
Gcv3 checkpoint could also be bypassed in a lip2 strain upon expression of B. 
subtilis LipL in the presence of excess free octanoate (Fig. 4.5). The effects of 
checkpoint bypass on the physiology of S. cerevisiae merits further study. 
The last known enzyme in the lipoate synthesis pathway of S. cerevisiae is Lip3. 
The substrate for Lip3 had not been identified prior to this work. Lip3 was shown 
to utilize octanoyl-CoA to activate PDH and OGDH. This substrate could come 
either directly from peroxisomal fatty acid β-oxidation or from an acyl-ACP:CoA 
transferase (Fig. 4.1). Free octanoate and octanoyl-Gcv3 were not substrates for 
Lip3 in vitro.   
83 
 
The simplest model which integrates our results with the reported lipoyl-Gcv3 
checkpoint is presented in Fig. 4.8.  In this model Lip2 specifically modifies Gcv3 
using octanoyl-ACP as substrate. When all the Gcv3 has been octanoylated, 
octanoyl-ACP accumulates. An octanoyl-ACP:CoA transferase then transfers the 
octanoyl moiety to CoA, providing the  substrate used by Lip3 to modify PDH and 
OGDH. The exact role of octanoyl-Gcv3 in the lipoylation pathway of S. 
cereviciae remains an open question. It is not clear why a gcv3 mutant doesn’t 
grow on ethanol even though wild type Lip3 is present and octanoyl-ACP is 
expected to accumulate in this mutant. Perhaps octanoyl-Gcv3 is required for 
expression, modification or mitochondrial targeting of either Lip3 or the octanoyl-
ACP:CoA transferase. It is worth noting that a second distinct role for Gcv3 in 
RNA processing has been reported in the literature (Schonauer et al., 2008). 
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Tables 
Table 4.1: Primers used in this study. Restriction endonuclease recognition 
sites are underlined. 
Name Sequence 
fadK-for GGGCCATGGAAGTGACATTAACGTTTAACG 
fadK-rev TCCAAGCTTATTCAATCTCTTCACAGACATCC 
pPICNTlip3-for CGCGGATCCACCATGCATCATCATCATCATCATTTTACA
CCTTCAAATGATAACG 
pPIClip3-rev GGGCGGCCGTTATGTGTAACTGTCAATATTCTCC 
mtlplA-for ACGTGGTACCATGTCCACATTACGCCTGCTC 
mtlplA-rev ACGTCTGCAGGCGGGTAACTACCTTACAGC 
mtlipB-for ACGTGGTACCTTGTATCAGGATAAAATTCTTGTCCGCCA
GCTCGG 
mtlipB-rev ACGTCTGCAGGGAATTAAGCGGTAATATATTCG 
mtlipL-for ACGTGGTACCATGGCAAACCAACCGATTGATTTACTG 
mtlipL-rev ACGTCTGCAGTTACCCAAATACCTTTGCATTCC 
 
 
 
Table 4.2: E. coli and yeast strains, and plasmids used in this study. 
Name Relevant Genotype Reference 
Yeast strains 
BY4741 S. cerevisiae MATa his3 leu2 met15 ura3 Open Biosystems 
lip2 S. cerevisiae MATa his3 leu2 met15 ura3 
lip2 
Open Biosystems 
lip3 S. cerevisiae  MATa his3 leu2 met15 ura3 
lip3 
Open Biosystems 
gcv3 S. cerevisiae  MATa his3 leu2 met15 ura3 
gcv3 
Open Biosystems 
GS115 P. pastoris his4 AOX1 AOX2 Invitrogen 
FH553 GC115 with pFH72 integrated at His4 
Expresses recombinant S. cerevisiae His-
tagged Lip3 under control of the methanol 
promoter. Lip3 lacks the mitochondrial 
targeting sequence and is expressed in the 
cytoplasm.  
This study 
E. coli strains 
QC146 MG1566 lipB::FRT lplA::FRT (Christensen and 
Cronan, 2009) 
RMK75 MG1655 fadK::FRT::cm (Morgan-Kiss and 
Cronan, 2004) 
FH306 QC146 carrying plasmid pFH23 (expresses 
Lip3) 
This study 
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Table 4.2 Continued. 
Name Relevant Genotype Reference 
FH307 FH306 fadD::FRT::cm This study 
FH437 QC146 carrying pTARA and pFH38. For 
expression of apo-Gcv3, under control of 
T7 promoter 
This study 
FH590 QC146 carrying pFH87. For expression of 
His tagged Lip2 under tac promoter. 
 
This study 
Plasmids 
pACYC177 Cloning vector (Rose, 1988) 
pBAD24 Cloning vector, arabinose promoter  (Guzman et al., 
1995) 
pBAD322C Cloning vector, arabinose promoter (Cronan, 2006) 
pCM188 E. coli- S. cerevisiae shuttle vector with YC-
type yeast replication, Ura3 selection, cyc1 
promoter and two tetO. 
(Gari et al., 1997) 
pMCSG7 Ligation-independent cloning vector, T7 
promoter 
(Eschenfeldt et al., 
2009) 
pPIC3.5K P. pastoris chromosomal integration vector Invitrogen 
pQC32 pBAD322G-lipL (Martin et al., 2011) 
pQE80K Expression vector, tac promoter Qiagen 
pRK33 pET16b-fadK (Morgan-Kiss and 
Cronan, 2004) 
pTARA pACYC origin, arabinose inducible T7 
polymerase 
(Wycuff and 
Matthews, 2000) 
pFH18 pBAD-lip2 in E. coli optimized codons This study 
pFH21 pBAD24-lip3 in E. coli optimized codons  
 
This study 
pFH23 pACYC177-lip3 in E. coli optimized codons 
under control of arabinose promoter 
This study 
pFH38 pMCSG7-gcv3 for expression of His tagged 
Gcv3 under T7 promoter  
This study 
pFH46 pUC vector carrying codons for the first 42 
amino acids of of S. cerevisiae Coq3 
(mitochondrial targeting sequence) 
between BamHI and KpnI + PstI cut sites  
This study 
pFH56 mtlplA on pCM188 This study 
pFH57 mtlipB on pCM188 This study 
pFH58 mtlipL on pCM188 This study 
pFH72 pPIC3.5K-lip3 This study 
pFH87 pQE80K-lip2 This study 
pFH88 pBAD322C-fadK This study 
pFH93 pFH23 derivative expressing K249A Lip3 This study 
pFH94 pFH23 derivative expressing K249R Lip3 This study 
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Figures 
A.
 
B.
 
Figure 4.1: Lip3 complementation of the E. coli ∆lipB ∆lplA strain QC146.  
A: Growth curves of strain QC146 carrying the Lip3 expression plasmid, pFH23, 
on either unsupplemented GMM or GMM supplemented with lipoate, octanoate, 
or a mixture of acetate and succinate as indicated.  
B: Replacing the Lip3 active site lysine (K249) with arginine or alanine greatly 
reduces or entirely eliminates the ability of Lip3 to support growth of QC146 on 
octanoate-supplemented GMM.   
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A. 
 
B. 
 
Figure 4.2: Detection of active lipoylated PDH and OGDH complexes in the 
E. coli ∆lipB ∆lplA strain QC146 expressing Lip3.  
A: PDH and OGDH were assayed in extracts of strain QC146 carrying either the 
empty vector (I) or a plasmid that expressed Lip3 under arabinose control (II – 
IV).  Growth medium was supplemented with lipoate or octanoate, both lipoate 
and octanoate or left unsupplemented as indicated. The highest levels of PDH 
and OGDH activities were observed in extracts of strain QC146 carrying the Lip3 
expression plasmid pFH23 when octanoate was present in the growth media 
(IV). * this result is significant relative to that of condition II (p-value = 0.003), and 
condition III (p-value = 0.02). Ŧ this result is significant relative to that of condition 
II (p-value = 0.0001), and condition III (p-value = 0.0005). Difference in PDH and 
OGDH activities between conditions II and III are not significant (not shown).   
B: Western blot analysis using anti-lipoyl LD antibody of extracts of the strain 
QC146 carrying pFH23 cultured in LB containing arabinose, acetate and 
succinate with either lipoate (lane 2), octanoate (lane 3) or neither (lane 1). 
Whereas lipoylated SucB (the LD of OGDH) was detected in all three extracts, 
lipoylated AceF (the LD of PDH) was detected only in cells grown the presence 
of octanoate (3).  
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A. 
 
B. 
 
Figure 4.3: Lip3 complementation of the E. coli ∆lipB ∆lplA strain QC146 on 
octanoate-supplemented GMM requires the presence of the fadD encoded 
acyl-CoA synthetase.  
A: Shown are GMM plates unsupplemented (plate A), supplemented with 
octanoate (plate B), or with succinate and acetate (plate C). The top sector of 
each plate are strain QC146 carrying a plasmid which expresses Lip3 whereas in 
the bottom sector of each plate the same strain carried a fadD deletion.  
B: Over expression of the FadK acyl-CoA synthetase amplifies Lip3 
complementation of the E. coli ∆lipB ∆lplA strain QC146. Growth curves on 
octanoate-supplemented GMM of QC146 carrying either the empty vector, a Lip3 
expression plasmid or plasmids expressing both Lip3 and FadK as indicated.  
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A. 
 
B. 
 
C.
 
Figure 4.4: 
A: In vitro detection of Lip3 octanoyl transferase activity by an 
electrophoresis mobility gel shift assay. Left gel: Lip3 reaction with LD with 
octanoyl-CoA (lane 1) or with ATP, octanoate and MgCl2 (lane 2). Right gel: Lip3 
activity with Gcv3 and octanoyl-CoA (lane 5). Lanes 3 and 4 were loaded with 
octanoyl-LD and apo-Gcv3 standards, respectively. Lip3 was active with both LD 
and Gcv3 when octanoyl-CoA was provided (lanes 1 and 5, respectively).  
B and C: Octanoyl-ACP is a substrate for Lip3, but not octanoyl-Gcv3. B: 
Electromobility gel shift assay with Lip3, Gcv3 and octanoyl-ACP from E. coli 
(lane 4). C: autoradiograph of Lip3 reaction with LD and various substrates: 
octanoyl-ACP from E. coli (lane 1) octanoyl-ACP from B. subtilis (lane 2), and 
octanoyl-Gcv3 (lane 3). Lane 4 is loaded with octanoyl-LD as standard. 
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Figure 4.5: Growth phenotypes of S. cerevisiae lip2, lip3 and gcv3 strains 
transformed with different plasmids. All strains were derivatives of BY4741 
and were grown on YP glucose, YP ethanol or YP ethanol supplemented with 
octanoate. Plates were incubated at 30o for up to four days. Panel A: the mutant 
strains transformed with empty vector. Panel B: the mutant strains transformed 
with pFH56 expressing mitochondrially targeted E. coli LplA. Panel C: the mutant 
strains transformed with pFH57 expressing mitochondrially targeted E. coli LipB. 
Panel D: the lip2 and lip3 strains transformed with pFH58 expressing 
mitochondrially targeted B. subtilis LipL.  
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Figure 4.6: 
A: Lip2 complements the E. coli ∆lipB ∆lplA strain QC146 on 
unsupplemented GMM. Left plate: Unsupplemented GMM.  Right plate: GMM 
supplemented with acetate and succinate. The left sector of each plate is strain 
QC146 carrying plasmid pFH18 which expresses Lip2. The right sector of each 
plate is strain QC146 carrying the empty vector.  
B: Assay of crude extract of a Lip2 expressing strain for octanoyl transferase 
activity in an electromobility gel shift assay. Octanoyltransferase activity is 
detected when octanoyl-ACP is provided as substrate (lane 5). No ligase activity 
is detected with octanoate + ATP + MgCl2 (lane 4). Octanoyl-LD is loaded in lane 
2 as standard. 
92 
 
 
Figure 4.7: Western blot analysis of wild type S. cerevisiea extracts using 
anti lipoyl-LD antibodies. Cells were cultured either in YP glucose (lanes 1 and 
2) or YP glycerol (lane 3). Whereas lipoyl-Gcv3 was detected in extracts from 
both culture conditions, lipoyl-Lat1 (the LD of PDH) and lipoyl-Kgd2 (the LD of 
OGDH) were detected only under respiratory conditions. 
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Figure 4.8: Proposed pathway for lipoate synthesis/ attachment in S. 
cerevisiae which accounts for the observed octanoyl-Gcv3 checkpoint. Left: 
Lip2 specifically modifies Gcv3 using octanoyl-ACP from mitochondrial FA 
biosynthesis. Right: When all Gcv3 is octanoylated, octanoyl-ACP accumulates. 
An octanoyl-ACP: CoA transferase transfers the octanoyl moiety to CoA, 
providing substrate for Lip3 to modify PDH and OGDH. Lip5 catalyzes the sulfur 
insertions on the octanoyl moiety once it is attached to an LD (not shown).     
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Chapter 5: Conclusions  
 
Lessons Learned from Escherichia coli 
The physiological requirement for lipoic acid is extremely low, only a few hundred 
molecules per cell. Yet under obligate aerobic growth conditions lipoic acid is 
essential because it is a coenzyme for pyruvate dehydrogenase (PDH) and 
oxoglutarate dehydrogenase (OGDH) which catalyze key steps in the TCA cycle. 
In E. coli, lipoate is assembled on the lipoyl domains (LDs) of PDH and OGDH 
from the eight carbon fatty acid, octanoate, in two steps. First, an 
octanoyltransferase (LipB) transfers an octanoyl moiety from the acyl carrier 
protein (ACP) of fatty acid synthesis to the LDs. Then lipoyl synthase (LipA) 
catalyzes replacement of single hydrogen atoms at carbons 6 and 8 with sulfur 
atoms using radical SAM chemistry. Alternatively, exogenous lipoate or 
octanoate can be directly attached to LDs by lipoate protein ligase (LplA). 
lipB null strains are expected to require acetate and succinate for aerobic growth 
on glucose minimal media. These supplements, respectively, bypass the PDH- 
and OGDH-catalyzed steps in the TCA cycle. Often times however, lipB strains 
exhibit a “leaky” growth phenotype, which relies on the presence of the lipA and 
lplA genes, and succinate (or lysine and methionine). Findings from this study 
offer an explanation for this phenomenon.  
In this study I characterized two types of lipB suppressors. In one type, described 
in chapter 2, suppression was caused by point mutations in the lplA coding 
region which resulted in enzymes with lowered Km for octanoate. This was 
perplexing because at the time no free fatty acids had been detected inside cells. 
However, with a careful procedure (gentle lysis and conversion of fatty acids to 
their butyl- instead of methyl- esters), I detected octanoate in the cytoplasm at a 
concentration of about 28 µM. Whereas this concentration is well below the Km 
for octanoate of the wild type LplA enzyme, it is above the Km of the mutant LplA 
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proteins. Thus the mutant LplA proteins enable activation of PDH and OGDH and 
thus growth of the lipB strain. 
The origin of cytoplasmic octanoate is unknown, but could be spontaneous 
hydrolysis of the thioester bond of the acyl-ACP of fatty acid biosynthesis. It is 
thus conceivable that strain background and/or growth conditions may affect the 
availability of free octanoate for lipoate synthesis by the LplA/LipA pathway and 
thus the potential for leaky growth of lipB strains. During characterization of the 
second type of suppressor (chapter 3), I observed that the lipB strain exhibited 
growth in the presence of only succinate supplementation and had functional 
PDH. The mutation causing suppression in this case turned out to be a stop 
codon in the sdhB gene which encodes a subunit of succinate dehydrogenase 
(SDH). So the question became how does inactivation of succinate catabolism in 
a strain defective in lipoate synthesis (and thus presumably OGDH activity) 
alleviate the requirement for exogenous succinate supplementation? There must 
be other sources of succinate! These other sources were identified as trace 
levels of OGDH, the isocitrate lyase of the glyoxylate shunt, and aspartate 
oxidase, the enzyme catalyzing the first step of nicotinamide biosynthesis. With 
this knowledge I was now able to knockout all the succinate-synthesis pathways 
and determine that only 250 nM of succinate were required to achieve half-
maximal growth in strains defective in succinate catabolism (SDH). This is greatly 
lower than the amount required for half maximal growth of strain containing 
functional SDH which is above 12 µM.  
Lessons Learned from Saccharomyces cerevisiae 
Although the LipA catalyzed reaction is conserved in all characterized lipoate 
synthesis pathways, there are three well-characterized variations to the E. coli 
pathway in the other reactions. In the lipoate auxotrophic archeon Thermoplasma 
acidophilum, the lipoate protein ligase is composed of two separately encoded 
subunits LplA and LplB that together catalyze formation of the acyl-AMP 
intermediate. The Gram-positive bacterium Bacillus subtilis lacks a LipB 
homologue, but encodes three LplA homologues, although only LplJ has the 
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ligase function of E. coli LplA. One of the two remaining homologues (LipM) is an 
octanoyltransferase that specifically transfers octanoate from ACP to a small 
protein, GcvH. Whereas LipL, the third homologue, is an amidotransferase that 
transfers the octanoyl moiety from GcvH to the LDs of PDH, the branched chain 
oxoacid dehydrogenase, and OGDH. LipL is also present in Listeria 
monocytogenes along with two other LplA homologues that are ligases. LplA1 
specifically modifies GcvH whereas the LD specificity of LplA2 is undetermined. 
The diversity in prokaryotic lipoate attachment mechanisms is surprising given 
the simple structure of the coenzyme. The situation in eukaryotes is not well 
understood. However with the characterization of the octanoyl-CoA: protein 
transferase activity of the S. cerevisiae lipoate protein ligase homologue (chapter 
4), it seems that eukaryotes may contribute further enzymatic diversity to this 
group of enzymes. 
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